AU771135B2 - Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin - Google Patents
Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin Download PDFInfo
- Publication number
- AU771135B2 AU771135B2 AU57796/01A AU5779601A AU771135B2 AU 771135 B2 AU771135 B2 AU 771135B2 AU 57796/01 A AU57796/01 A AU 57796/01A AU 5779601 A AU5779601 A AU 5779601A AU 771135 B2 AU771135 B2 AU 771135B2
- Authority
- AU
- Australia
- Prior art keywords
- oxygenase
- plant
- chromoplasts
- ccc
- chloroplasts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000001168 astaxanthin Substances 0.000 title description 78
- 229940022405 astaxanthin Drugs 0.000 title description 78
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title description 76
- 235000013793 astaxanthin Nutrition 0.000 title description 76
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title description 76
- 230000015572 biosynthetic process Effects 0.000 title description 53
- 241000168517 Haematococcus lacustris Species 0.000 title description 38
- 150000007523 nucleic acids Chemical group 0.000 title description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 title description 10
- 235000021466 carotenoid Nutrition 0.000 claims description 150
- 150000001747 carotenoids Chemical class 0.000 claims description 150
- 210000004027 cell Anatomy 0.000 claims description 94
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 60
- 210000002706 plastid Anatomy 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 47
- 210000001519 tissue Anatomy 0.000 claims description 41
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 39
- 210000003763 chloroplast Anatomy 0.000 claims description 37
- 229920001184 polypeptide Polymers 0.000 claims description 37
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 31
- 230000000694 effects Effects 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 23
- 108090000417 Oxygenases Proteins 0.000 claims description 4
- 102000004020 Oxygenases Human genes 0.000 claims description 2
- 238000012827 research and development Methods 0.000 claims description 2
- 230000002222 downregulating effect Effects 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 92
- 108090000623 proteins and genes Proteins 0.000 description 72
- 239000013612 plasmid Substances 0.000 description 62
- 108020004414 DNA Proteins 0.000 description 56
- 241000588724 Escherichia coli Species 0.000 description 53
- 101150058715 crtO gene Proteins 0.000 description 50
- 239000002299 complementary DNA Substances 0.000 description 44
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 42
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 41
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 37
- 102000004190 Enzymes Human genes 0.000 description 37
- 108090000790 Enzymes Proteins 0.000 description 37
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 36
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 32
- 230000009261 transgenic effect Effects 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 28
- 240000003768 Solanum lycopersicum Species 0.000 description 26
- 239000002773 nucleotide Substances 0.000 description 26
- 125000003729 nucleotide group Chemical group 0.000 description 25
- 239000000047 product Substances 0.000 description 25
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 24
- 235000008210 xanthophylls Nutrition 0.000 description 24
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 23
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 23
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 23
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 23
- 235000010930 zeaxanthin Nutrition 0.000 description 23
- 239000001775 zeaxanthin Substances 0.000 description 23
- 229940043269 zeaxanthin Drugs 0.000 description 23
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 22
- 241000192700 Cyanobacteria Species 0.000 description 22
- 235000012682 canthaxanthin Nutrition 0.000 description 21
- 239000001659 canthaxanthin Substances 0.000 description 21
- 229940008033 canthaxanthin Drugs 0.000 description 21
- 108020004511 Recombinant DNA Proteins 0.000 description 20
- 238000012512 characterization method Methods 0.000 description 20
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 19
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 19
- 239000012634 fragment Substances 0.000 description 19
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 18
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 description 18
- 241000588912 Pantoea agglomerans Species 0.000 description 18
- -1 astaxanthin Chemical class 0.000 description 18
- 230000000243 photosynthetic effect Effects 0.000 description 18
- 235000011765 phytoene Nutrition 0.000 description 18
- 102000053602 DNA Human genes 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 17
- 239000013598 vector Substances 0.000 description 17
- 239000004009 herbicide Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 15
- 150000001746 carotenes Chemical class 0.000 description 15
- 235000005473 carotenes Nutrition 0.000 description 15
- 229930002875 chlorophyll Natural products 0.000 description 15
- 235000019804 chlorophyll Nutrition 0.000 description 15
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 15
- 235000012661 lycopene Nutrition 0.000 description 15
- 239000001751 lycopene Substances 0.000 description 15
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 15
- 229960004999 lycopene Drugs 0.000 description 15
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 15
- 241000195493 Cryptophyta Species 0.000 description 14
- 101150108119 PDS gene Proteins 0.000 description 14
- 239000012528 membrane Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 101150028535 CRTZ gene Proteins 0.000 description 13
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 13
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 13
- 241000135402 Synechococcus elongatus PCC 6301 Species 0.000 description 13
- 241000192560 Synechococcus sp. Species 0.000 description 13
- 238000010367 cloning Methods 0.000 description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 13
- 229960005375 lutein Drugs 0.000 description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 244000061176 Nicotiana tabacum Species 0.000 description 12
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 12
- 230000002363 herbicidal effect Effects 0.000 description 12
- 230000029553 photosynthesis Effects 0.000 description 12
- 238000010672 photosynthesis Methods 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 150000003735 xanthophylls Chemical class 0.000 description 12
- 241000589158 Agrobacterium Species 0.000 description 11
- 108091026890 Coding region Proteins 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- OOUTWVMJGMVRQF-NWYYEFBESA-N Phoenicoxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C OOUTWVMJGMVRQF-NWYYEFBESA-N 0.000 description 11
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 239000000049 pigment Substances 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000002955 isolation Methods 0.000 description 10
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 9
- 101710173432 Phytoene synthase Proteins 0.000 description 9
- 238000009360 aquaculture Methods 0.000 description 9
- 244000144974 aquaculture Species 0.000 description 9
- 101150081158 crtB gene Proteins 0.000 description 9
- 101150000046 crtE gene Proteins 0.000 description 9
- 101150091072 crtP gene Proteins 0.000 description 9
- 235000006932 echinenone Nutrition 0.000 description 9
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 238000010369 molecular cloning Methods 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 9
- ATCICVFRSJQYDV-UHFFFAOYSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C ATCICVFRSJQYDV-UHFFFAOYSA-N 0.000 description 8
- 239000003086 colorant Substances 0.000 description 8
- 239000002778 food additive Substances 0.000 description 8
- 230000004345 fruit ripening Effects 0.000 description 8
- 238000007363 ring formation reaction Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 150000003505 terpenes Chemical group 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- YECXHLPYMXGEBI-DOYZGLONSA-N Adonixanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C YECXHLPYMXGEBI-DOYZGLONSA-N 0.000 description 7
- 241000192589 Synechococcus elongatus PCC 7942 Species 0.000 description 7
- YECXHLPYMXGEBI-ZNQVSPAOSA-N adonixanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C YECXHLPYMXGEBI-ZNQVSPAOSA-N 0.000 description 7
- 150000001749 carotenones Chemical class 0.000 description 7
- 235000005472 carotenones Nutrition 0.000 description 7
- 235000013373 food additive Nutrition 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 108060004506 lycopene beta-cyclase Proteins 0.000 description 7
- 108060004507 lycopene cyclase Proteins 0.000 description 7
- NVGOPFQZYCNLDU-UHFFFAOYSA-N norflurazon Chemical compound O=C1C(Cl)=C(NC)C=NN1C1=CC=CC(C(F)(F)F)=C1 NVGOPFQZYCNLDU-UHFFFAOYSA-N 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 239000013600 plasmid vector Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 239000006137 Luria-Bertani broth Substances 0.000 description 6
- 241000221961 Neurospora crassa Species 0.000 description 6
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 6
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 6
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 description 6
- 241000192707 Synechococcus Species 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 101150011633 crtI gene Proteins 0.000 description 6
- 101150085103 crtY gene Proteins 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 6
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000002853 nucleic acid probe Substances 0.000 description 6
- 230000003711 photoprotective effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000002566 Capsicum Nutrition 0.000 description 5
- 239000004212 Cryptoxanthin Substances 0.000 description 5
- 241001464430 Cyanobacterium Species 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 101100061456 Streptomyces griseus crtB gene Proteins 0.000 description 5
- 241000192581 Synechocystis sp. Species 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 238000006356 dehydrogenation reaction Methods 0.000 description 5
- 229910001882 dioxygen Inorganic materials 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- RVCNKTPCHZNAAO-UZDKSQMHSA-N (1R,2R,3R)-prephytoene diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)[C@]1(C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C RVCNKTPCHZNAAO-UZDKSQMHSA-N 0.000 description 4
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 4
- 241000972773 Aulopiformes Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 102100039291 Geranylgeranyl pyrophosphate synthase Human genes 0.000 description 4
- 241000234479 Narcissus Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- ATCICVFRSJQYDV-DDRHJXQASA-N Neurosporene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C ATCICVFRSJQYDV-DDRHJXQASA-N 0.000 description 4
- 241000588696 Pantoea ananatis Species 0.000 description 4
- 241000191023 Rhodobacter capsulatus Species 0.000 description 4
- 241000277331 Salmonidae Species 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 101100463169 Synechococcus elongatus (strain PCC 7942 / FACHB-805) pds gene Proteins 0.000 description 4
- 239000004213 Violaxanthin Substances 0.000 description 4
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 4
- 238000013452 biotechnological production Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 238000005805 hydroxylation reaction Methods 0.000 description 4
- 235000008665 neurosporene Nutrition 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 235000015927 pasta Nutrition 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019245 violaxanthin Nutrition 0.000 description 4
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 4
- ZRCXVNZZDQGBQT-XQIHNALSSA-N (3'R)-3'-hydroxy-echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)CCC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C ZRCXVNZZDQGBQT-XQIHNALSSA-N 0.000 description 3
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 3
- ZRCXVNZZDQGBQT-ZMSRUZMRSA-N 3'-Hydroxyechinenone Natural products O=C1C(C)=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@@H](O)CC=2C)\C)/C)\C)/C)C(C)(C)CC1 ZRCXVNZZDQGBQT-ZMSRUZMRSA-N 0.000 description 3
- ZRCXVNZZDQGBQT-BANQPSJHSA-N 3'-hydroxyechinenone Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C ZRCXVNZZDQGBQT-BANQPSJHSA-N 0.000 description 3
- JCRCKXUPYKELBT-QQGJMDNJSA-N 4-hydroxy-all-trans-beta-carotene Chemical compound CC=1C(O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C JCRCKXUPYKELBT-QQGJMDNJSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000192531 Anabaena sp. Species 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000588699 Erwinia sp. Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010007508 Farnesyltranstransferase Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 241000078013 Trichormus variabilis Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- JCRCKXUPYKELBT-ITUXNECMSA-N all-trans isocryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(O)CCC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C JCRCKXUPYKELBT-ITUXNECMSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 3
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 238000010352 biotechnological method Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 description 3
- 235000019244 cryptoxanthin Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 108091008053 gene clusters Proteins 0.000 description 3
- 108010050848 glycylleucine Proteins 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000033444 hydroxylation Effects 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 235000002677 phytofluene Nutrition 0.000 description 3
- OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 description 3
- ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 2
- DFNMSBYEEKBETA-JZLJSYQFSA-N 3-Hydroxyechinenone Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DFNMSBYEEKBETA-JZLJSYQFSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- 241000588986 Alcaligenes Species 0.000 description 2
- 241000192698 Aphanocapsa Species 0.000 description 2
- JZRLLSOWDYUKOK-SRVKXCTJSA-N Asn-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N JZRLLSOWDYUKOK-SRVKXCTJSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- HRMMVZISPQOKMU-KKUMJFAQSA-N Cys-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CS)N)O HRMMVZISPQOKMU-KKUMJFAQSA-N 0.000 description 2
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
- 241000588698 Erwinia Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 2
- 241000873641 Gloeocapsa alpicola Species 0.000 description 2
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 2
- CSTNMMIHMYJGFR-IHRRRGAJSA-N His-His-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CN=CN1 CSTNMMIHMYJGFR-IHRRRGAJSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 2
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 2
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 2
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 2
- QWTGQXGNNMIUCW-BPUTZDHNSA-N Met-Asn-Trp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QWTGQXGNNMIUCW-BPUTZDHNSA-N 0.000 description 2
- 108010085220 Multiprotein Complexes Proteins 0.000 description 2
- 102000007474 Multiprotein Complexes Human genes 0.000 description 2
- 241001478892 Nostoc sp. PCC 7120 Species 0.000 description 2
- 101100168661 Paracoccus sp. (strain N81106 / MBIC 01143) crtW gene Proteins 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 2
- FRMKIPSIZSFTTE-HJOGWXRNSA-N Phe-Tyr-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FRMKIPSIZSFTTE-HJOGWXRNSA-N 0.000 description 2
- 108010059332 Photosynthetic Reaction Center Complex Proteins Proteins 0.000 description 2
- 108010081996 Photosystem I Protein Complex Proteins 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- GFUOTIPYXKAPAH-BVSLBCMMSA-N Trp-Pro-Phe Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GFUOTIPYXKAPAH-BVSLBCMMSA-N 0.000 description 2
- BVWADTBVGZHSLW-IHRRRGAJSA-N Tyr-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N BVWADTBVGZHSLW-IHRRRGAJSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 230000008436 biogenesis Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000002113 chemopreventative effect Effects 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- 108091000085 chlorophyll binding Proteins 0.000 description 2
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 101150109357 crtL gene Proteins 0.000 description 2
- 101150034345 crtQ gene Proteins 0.000 description 2
- 101150022865 crtX gene Proteins 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 238000002267 linear dichroism spectroscopy Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 238000007479 molecular analysis Methods 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000007539 photo-oxidation reaction Methods 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 230000002319 phototactic effect Effects 0.000 description 2
- 231100000760 phototoxic Toxicity 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- DFNMSBYEEKBETA-FXGCUYOLSA-N rac-3-Hydroxyechinenon Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DFNMSBYEEKBETA-FXGCUYOLSA-N 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 210000002377 thylakoid Anatomy 0.000 description 2
- 108010060747 zeaxanthin glucosyltransferase Proteins 0.000 description 2
- OCMSUPSDVXKDFY-UHFFFAOYSA-N (3E)-3,4-didehydro-psi,psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)C=CC=C(C)C OCMSUPSDVXKDFY-UHFFFAOYSA-N 0.000 description 1
- MUCOHWBULSBLLZ-LSUAHRBSSA-N (3R,4S,5S,6R)-2-[(3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E)-2-hydroxy-25-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-2,6,10,14,19,23-hexamethylpentacosa-4,6,8,10,12,14,16,18,20,22,24-undecaen-3-yl]oxy-6-methyloxane-3,4,5-triol Chemical compound C[C@H]1OC(O[C@@H](\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)O)[C@H](O)[C@@H](O)[C@@H]1O MUCOHWBULSBLLZ-LSUAHRBSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RPNMGUBLKCLAEK-UHFFFAOYSA-N 2-(4-chlorophenyl)sulfanyl-n,n-diethylethanamine;hydrochloride Chemical compound [Cl-].CC[NH+](CC)CCSC1=CC=C(Cl)C=C1 RPNMGUBLKCLAEK-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- 108091027075 5S-rRNA precursor Proteins 0.000 description 1
- OFNSUWBAQRCHAV-UHFFFAOYSA-N 9-cis-antheraxanthin Natural products O1C(CC(O)CC2(C)C)(C)C12C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C OFNSUWBAQRCHAV-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- SITWEMZOJNKJCH-WDSKDSINSA-N Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SITWEMZOJNKJCH-WDSKDSINSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 1
- MAEQBGQTDWDSJQ-LSJOCFKGSA-N Ala-Met-His Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MAEQBGQTDWDSJQ-LSJOCFKGSA-N 0.000 description 1
- JNLDTVRGXMSYJC-UVBJJODRSA-N Ala-Pro-Trp Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JNLDTVRGXMSYJC-UVBJJODRSA-N 0.000 description 1
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UFBFGSQYSA-N Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UFBFGSQYSA-N 0.000 description 1
- CKIBTNMWVMKAHB-RWGOJESNSA-N Ala-Trp-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 CKIBTNMWVMKAHB-RWGOJESNSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- OFNSUWBAQRCHAV-MATJVGBESA-N Antheraxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)\C)/C)\C)/C)=C(C)C1 OFNSUWBAQRCHAV-MATJVGBESA-N 0.000 description 1
- JSLGXODUIAFWCF-WDSKDSINSA-N Arg-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O JSLGXODUIAFWCF-WDSKDSINSA-N 0.000 description 1
- SLNCSSWAIDUUGF-LSJOCFKGSA-N Arg-His-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O SLNCSSWAIDUUGF-LSJOCFKGSA-N 0.000 description 1
- WQSCVMQDZYTFQU-FXQIFTODSA-N Asn-Cys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WQSCVMQDZYTFQU-FXQIFTODSA-N 0.000 description 1
- GADKFYNESXNRLC-WDSKDSINSA-N Asn-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GADKFYNESXNRLC-WDSKDSINSA-N 0.000 description 1
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- NAAAPCLFJPURAM-HJGDQZAQSA-N Asp-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O NAAAPCLFJPURAM-HJGDQZAQSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 102100021277 Beta-secretase 2 Human genes 0.000 description 1
- 101710150190 Beta-secretase 2 Proteins 0.000 description 1
- 235000006463 Brassica alba Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 101100243399 Caenorhabditis elegans pept-2 gene Proteins 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- RGTVXXNMOGHRAY-WDSKDSINSA-N Cys-Arg Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RGTVXXNMOGHRAY-WDSKDSINSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010047524 Deoxyribonuclease HindIII Proteins 0.000 description 1
- PVNVIBOWBAPFOE-UHFFFAOYSA-N Dinoxanthin Natural products CC1(O)CC(OC(=O)C)CC(C)(C)C1=C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1(C(CC(O)C2)(C)C)C2(C)O1 PVNVIBOWBAPFOE-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- YWBVHLJPRPCRSD-UHFFFAOYSA-N Fluridone Chemical compound O=C1C(C=2C=C(C=CC=2)C(F)(F)F)=CN(C)C=C1C1=CC=CC=C1 YWBVHLJPRPCRSD-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 1
- 108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 1
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 1
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 1
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 1
- CTJHHEQNUNIYNN-SRVKXCTJSA-N His-His-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O CTJHHEQNUNIYNN-SRVKXCTJSA-N 0.000 description 1
- TTYKEFZRLKQTHH-MELADBBJSA-N His-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O TTYKEFZRLKQTHH-MELADBBJSA-N 0.000 description 1
- MDOBWSFNSNPENN-PMVVWTBXSA-N His-Thr-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O MDOBWSFNSNPENN-PMVVWTBXSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 108010065958 Isopentenyl-diphosphate Delta-isomerase Proteins 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 241001080283 Leptolyngbya lurida Species 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- LAGPXKYZCCTSGQ-JYJNAYRXSA-N Leu-Glu-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LAGPXKYZCCTSGQ-JYJNAYRXSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 1
- BGGTYDNTOYRTTR-MEYUZBJRSA-N Leu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(C)C)N)O BGGTYDNTOYRTTR-MEYUZBJRSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 1
- YEIYAQQKADPIBJ-GARJFASQSA-N Lys-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O YEIYAQQKADPIBJ-GARJFASQSA-N 0.000 description 1
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 1
- ULUQBUKAPDUKOC-GVXVVHGQSA-N Lys-Glu-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ULUQBUKAPDUKOC-GVXVVHGQSA-N 0.000 description 1
- CTBMEDOQJFGNMI-IHPCNDPISA-N Lys-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCCCN)N CTBMEDOQJFGNMI-IHPCNDPISA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 description 1
- CAEZLMGDJMEBKP-AVGNSLFASA-N Met-Pro-His Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CNC=N1 CAEZLMGDJMEBKP-AVGNSLFASA-N 0.000 description 1
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 1
- XYVRXLDSCKEYES-JSGCOSHPSA-N Met-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 XYVRXLDSCKEYES-JSGCOSHPSA-N 0.000 description 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- MUCOHWBULSBLLZ-UHFFFAOYSA-N Myxoxanthophyll Natural products OC1C(O)C(O)C(C)OC1OC(C(C)(C)O)C=CC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C MUCOHWBULSBLLZ-UHFFFAOYSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 101710197978 NADPH-dependent oxidoreductase Proteins 0.000 description 1
- 241001532689 Narcissus pseudonarcissus Species 0.000 description 1
- 235000005807 Nelumbo Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001542817 Phaffia Species 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- JVTMTFMMMHAPCR-UBHSHLNASA-N Phe-Ala-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JVTMTFMMMHAPCR-UBHSHLNASA-N 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- OZILORBBPKKGRI-RYUDHWBXSA-N Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 OZILORBBPKKGRI-RYUDHWBXSA-N 0.000 description 1
- AGYXCMYVTBYGCT-ULQDDVLXSA-N Phe-Arg-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O AGYXCMYVTBYGCT-ULQDDVLXSA-N 0.000 description 1
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 1
- BYAIIACBWBOJCU-URLPEUOOSA-N Phe-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BYAIIACBWBOJCU-URLPEUOOSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 1
- QTVUPXHPSXZJKH-ULQDDVLXSA-N Phe-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N QTVUPXHPSXZJKH-ULQDDVLXSA-N 0.000 description 1
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 1
- 241000235400 Phycomyces Species 0.000 description 1
- 241000192524 Planktothrix agardhii Species 0.000 description 1
- 241000694540 Pluvialis Species 0.000 description 1
- 102000019337 Prenyltransferases Human genes 0.000 description 1
- 108050006837 Prenyltransferases Proteins 0.000 description 1
- JQOHKCDMINQZRV-WDSKDSINSA-N Pro-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 JQOHKCDMINQZRV-WDSKDSINSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 1
- UEKYKRQIAQHOOZ-KBPBESRZSA-N Pro-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)[O-])C(=O)[C@@H]1CCC[NH2+]1 UEKYKRQIAQHOOZ-KBPBESRZSA-N 0.000 description 1
- MCPXQHVVCPTRIM-HJOGWXRNSA-N Pro-Trp-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)[C@@H]1CCCN1 MCPXQHVVCPTRIM-HJOGWXRNSA-N 0.000 description 1
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- STIAINRLUUKYKM-WFBYXXMGSA-N Ser-Trp-Ala Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 STIAINRLUUKYKM-WFBYXXMGSA-N 0.000 description 1
- YXGCIEUDOHILKR-IHRRRGAJSA-N Ser-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CO)N YXGCIEUDOHILKR-IHRRRGAJSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000192500 Spirulina sp. Species 0.000 description 1
- 241000192593 Synechocystis sp. PCC 6803 Species 0.000 description 1
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 1
- IGGFFPOIFHZYKC-PBCZWWQYSA-N Thr-His-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O IGGFFPOIFHZYKC-PBCZWWQYSA-N 0.000 description 1
- VMSSYINFMOFLJM-KJEVXHAQSA-N Thr-Tyr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCSC)C(=O)O)N)O VMSSYINFMOFLJM-KJEVXHAQSA-N 0.000 description 1
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 1
- PEYSVKMXSLPQRU-FJHTZYQYSA-N Trp-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O PEYSVKMXSLPQRU-FJHTZYQYSA-N 0.000 description 1
- DZHDVYLBNKMLMB-ZFWWWQNUSA-N Trp-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 DZHDVYLBNKMLMB-ZFWWWQNUSA-N 0.000 description 1
- FBVGQXJIXFZKSQ-GMVOTWDCSA-N Tyr-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N FBVGQXJIXFZKSQ-GMVOTWDCSA-N 0.000 description 1
- KGSDLCMCDFETHU-YESZJQIVSA-N Tyr-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O KGSDLCMCDFETHU-YESZJQIVSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- RQOMPQGUGBILAG-AVGNSLFASA-N Val-Met-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O RQOMPQGUGBILAG-AVGNSLFASA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010017893 alanyl-alanyl-alanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- PGYAYSRVSAJXTE-CLONMANBSA-N all-trans-neoxanthin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C=C=C1C(C)(C)C[C@H](O)C[C@@]1(C)O PGYAYSRVSAJXTE-CLONMANBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- OFNSUWBAQRCHAV-OYQUVCAXSA-N antheraxanthin Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C OFNSUWBAQRCHAV-OYQUVCAXSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 229930003362 apo carotenoid Natural products 0.000 description 1
- 125000000135 apo carotenoid group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000019646 color tone Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 101150079391 crtW gene Proteins 0.000 description 1
- 150000001922 cyclic carotenes Chemical class 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 108010056141 cytochrome b559 Proteins 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- OINNEUNVOZHBOX-KGODAQDXSA-N geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C(C)=C\CO[P@@](O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-KGODAQDXSA-N 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 229940084937 glyset Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- DVCSNHXRZUVYAM-BQBZGAKWSA-N leu-asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 108010034507 methionyltryptophan Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- OWAAYLVMANNJOG-OAKWGMHJSA-N neoxanthin Natural products CC(=C/C=C(C)/C=C/C=C(C)/C=C=C1C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC23OC2(C)CC(O)CC3(C)C OWAAYLVMANNJOG-OAKWGMHJSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 230000029264 phototaxis Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000007731 primary charge separation Effects 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004844 protein turnover Effects 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 108010045269 tryptophyltryptophan Proteins 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- OFNSUWBAQRCHAV-KYHIUUMWSA-N zeaxanthin monoepoxide Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C OFNSUWBAQRCHAV-KYHIUUMWSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Description
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT Applicant(s): YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM Invention Title: NUCLEIC ACID SEQUENCE ENCODING BETA-C-4-OXYGENASE FROM HAEMATOCOCCUS PLUVIALIS FOR THE BIOSYNTHESIS OF
ASTAXANTHIN.
The following statement is a full description of this invention, including the best method of performing it known to me/us: r NUCLEIC ACID SEQUENCE ENCODING BETA-C-4-OXYGENASE FROM HAEMATOCOCCUS PLUVIALIS FOR THE BIOSYNTHESIS OF ASTAXANTHIN FIELD ANDBACKGROUND OF THE INVENTION The present invention relates, in general, to a biotechnological method for production of (3S,3'S) astaxanthin. In particular, the present invention relates to a peptide having a P-C-4-oxygenase activity; a DNA segment coding for this peptide; an RNA segments coding for this peptide; a recombinant DNA molecule comprising a vector and the DNA segment; a host cell or organism containing the above described recombinant DNA molecule or DNA segment; and to a method of biotechnologically producing (3S,3'S) astaxanthin or a food additive containing (3S,3'S) astaxanthin, using the host.
Carotenoids, such as astaxanthin, are natural pigments that are responsible for rhany of the yellow, orange and red colors seen in living organisms.
Carotenoids are widely distributed in nature and have, in various living systems, two main biological functions: they serve as light-harvesting pigments in photosynthesis, and they protect against photooxidative damage. These and additional biological functions of carotenoids, their important industrial role, and their biosynthesis are discussed hereinbelow.
As part of the light-harvesting antenna, carotenoids can absorb photons and transfer the energy to chlorophyll, thus assisting in the harvesting of light in the 25 range of 450 570 nm [see, Cogdell RJ and Frank HA (1987) How carotenoids function in photosynthestic bacteria. Biochim Biophys Acta 895: 63-79; Cogdell R (1988) The function of pigments in chloroplasts. In: Goodwin TW (ed) Plant Pigments, pp 183-255. Academic Press, London; Frank HA, Violette CA, Trautman JK, Shreve AP, Owens TG and Albrecht AC (1991) Carotenoids in 30 photosynthesis: structure and photochemistry. Pure Appl Chem 63: 109-114; Frank HA, Farhoosh R, Decoster B and Christensen RL (1992) Molecular features that control the efficiency of carotenoid-to-chlorophyll energy transfer in photosynthesis. In: Murata N (ed) Research in Photosynthesis, Vol I, pp 125-128.
Kluwer, Dordrecht; and, Cogdell RJ and Gardiner AT (1993) Functions of 35 carotenoids in photosynthesis. Meth Enzymol 214: 185-193]. Although carotenoids are integral constituents of the protein-pigment complexes of the lightharvesting antennae in photosynthetic organisms, they are also important components of the photosynthetic reaction centers.
Most of the total carotenoids is located in the light harvesting complex II [Bassi R, Pineaw B, Dainese P and Marquartt J (1993) Carotenoid binding proteins of photosystem II. Eur J Biochem 212: 297-302]. The identities of the plotosynthetically active carotenoproteins and their precise location in lightharvesting systems are not known. Carotenoids in photochemically active chlorophyll-protein complexes of the thermophilic cyanobacterium Svnechococcus sp. were investigated by linear dichroism spectroscopy of oriented samples [see, Breton J and Kato S (1987) Orientation of the pigments in photosystem II: lowtemperature linear-dichroism study of a core particle and of its chlorophyll-protein subunits isolated from Synechococcus sp. Biochim Biophys Acta 892: 99-107].
These complexes contained mainly a P-carotene pool absorbing around 505 and 470 nm. which is oriented close to the membrane plane. In photochemically inactive chlorophyll-protein complexes, the P-carotene absorbs around 495 and 465 nm. and the molecules are oriented perpendicular to the membrane plane.
Evidence that carotenoids are associated with cyanobacterial photosystem (PS) II has been described [see, Suzuki R and Fujita Y (1977) Carotenoid photobleaching induced by the action of photosynthetic reaction center II: DCMU sensitivity. Plant Cell Physiol 18: 625-631; and, Newman PJ and Sherman LA (1978) Isolation and characterization of photosystem I and II membrane particles from the blue-green alga Synechococcus cedrorum. Biochim Biophys Acta 503: 343-361]. There are two p-carotene molecules in the reaction center core of PS II [see, Ohno T, Satoh K and Katoh S (1986) Chemical composition of purified oxygen-evolving complexes from the thermophilic cyanobacterium Synechococcus sp. Biochim Biophys Acta 852: 1-8; Gounaris K, Chapman DJ and Barber J (1989) 25 Isolation and characterization of a D1/D2/cytochrome b-559 complex from Synechocystis PCC6803. Biochim Biophys Acta 973: 296-301; and, Newell RW, van Amerongen H, Barber J and van Grondelle R (1993) Spectroscopic characterization of'the reaction center of photosystem II using polarized light: Evidence for 0-carotene excitors in PS II reaction centers. Biochim Biophys Acta 1057: 232-238] whose exact function(s) is still obscure [reviewed by Satoh K (1992) Structure and function of PS II reaction center. In: Murata N (ed) Research in Photosynthesis, Vol. II, pp. 3-12. Kluwer, Dordrecht]. It was demonstrated that these two coupled P-carotene molecules protect chlorophyll P680 from o photodamage in isolated PS II reaction centers [see, De Las Rivas J, Telfer A and 35 Barber J (1993) 2-coupled p-carotene molecules protect P680 from photodamage in isolated PS II reaction centers. Biochim. Biophys. Acta 1142: 155-164], and this may be related to the protection against degradation of the DI subunit of PS II [see, Sandmann G (1993) Genes and enzymes involved in the desaturation reactions from phytoene to lycopene. (abstract), 10th International Symposium on Carotenoids, Trondheim CL1-2]. The light-harvesting pigments of a highly purified, oxygen-evolving PS II complex of the thermophilic cyanobacterium Svnechococcus sp. consists of 50 chlorophyll a and 7 p-carotene, but no xanthophyll, molecules [see, Ohno T, Satoh K and Katoh S (1986) Chemical composition of purified oxygen-evolving complexes from the thermophilic cyanobacterium Synechococcus sp. Biochim Biophys Acta 852: P-carotene was shown to play a role in the assembly of an active PS II in green algae [see, Humbeck K, Romer S and Senger H (1989) Evidence for the essential role of o0 carotenoids in the assembly of an active PS II. Planta 179: 242-250].
Isolated complexes of PS I from Phormidium luridum, which contained chlorophylls per P700, contained an average of 1.3 molecules of p-carotene [see, Thornber JP, Alberte RS, Hunter FA, Shiozawa JA and Kan KS (1976) The organization of chlorophyll in the plant photosynthetic unit. Brookhaven Symp Biology 28: 132-148]. ,n a preparation of PS I particles from Synechococcus sp.
strain PCC 6301, which contained 130 5 molecules of antenna chlorophylls per P700, 16 molecules of carotenoids were detected [see, Lundell DJ, Glazer AN, Melis A and Malkin R (1985) Characterization of a cyanobacterial photosystem I complex. J Biol Chem 260: 646-654]. A substantial content of p-carotene and the xanthophylls cryptoxanthin and isocryptoxanthin were detected in PS I pigmentprotein complexes of the thermophilic cyanobacterium Synechococcus elongatus [see, Coufal J, Hladik J and Sofrova D (1989) The carotenoid content of photosystem 1 pigment-protein complexes of the cyanobacterium Synechococcus elongatus. Photosynthetica 23: 603-616]. A subunit protein-complex structure of 25 PS I from the thermophilic cyanobacterium Synechococcus sp., which consisted of four polypeptides (of 62, 60, 14 and 10 kDa), contained approximately 10 Pcarotene molecules per P700 [see, Takahashi Y, Hirota K and Katoh S (1985) Multiple forms of P700-chlorophyll a-protein complexes from Synechococcus sp.: the iron, quinone and carotenoid contents. Photosynth Res 6: 183-192]. This carotenoid is exclusively bound to the large polypeptides which carry the functional and antenna chlorophyll a. The fluorescence excitation spectrum of these -complexes suggested that p-carotene serves as an efficient antenna for PS I.
As mentioned, an additional essential function of carotenoids is to protect S against photooxidation processes in the photosynthetic apparatus that are caused by the excited triplet state of chlorophyll. Carotenoid molecules with xt-electron conjugation of nine or more carbon-carbon double bonds can absorb triplet-state energy from chlorophyll and thus prevent the formation of harmful singlet-state oxygen radicals. In Synechococcus sp. the triplet state of carotenoids was monitored in closed PS II centers and its rise kinetics of approximately nanoseconds is attributed to energy transfer from chlorophyll triplets in the antenna [see, Schlodder E and Brettel K (1988) Primary charge separation. in closed photosystem II with a lifetime of 11 nanoseconds. Flash-absorption spectroscopy with oxygen-evolving photosystem II complexes from Synechococcus. Biochim Biophys Acta 933: 22-34]. It is conceivable that this process, that has a lower yield compared to the yield of radical-pair formation, plays a role in protecting chlorophyll from damage due to over-excitation.
The protective role of carotenoids in vivo has been elucidated through the I0 use of bleaching herbicides such as norflurazon that inhibit carotenoid biosynthesis in all organisms performing oxygenic photosynthesis [reviewed by Sandmann G and Boger P (1989) Inhibition of carotenoid biosynthesis by herbicides. In: Boger P and Sandmann G (Eds.) Target Sites of Herbicide Action, pp 25-44. CRC Press, Boca Raton, Florida]. Treatment with norflurazon in the light results in a decrease of both carotenoid and chlorophyll levels,,while in the dark,,chlorophyll levels are unaffected. Inhibition of photosynthetic efficiency in cells of Oscillatoria agardhii that were treated with the pyridinone herbicide, fluridone, was attributed to a decrease in the relative abundance of myxoxanthophyll, zeaxanthin and 3carotene, which in turn caused photooxidation of chlorophyll molecules [see, Canto de Loura I, Dubacq JP and Thomas JC (1987) The effects of nitrogen deficiency on pigments and lipids ofcianobacteria. Plant Physiol 83: 838-843].
It has been demonstrated in plants that zeaxanthin is required to dissipate, in a nonradiative manner, the excess excitation energy of the antenna chlorophyll [see, Demmig-Adams B (1990) Carotenoids and photoprotection in plants: a role 25 for the xanthophyll zeaxanthin. Biochim Biophys Acta 1020: 1-24; and, Demmig- Adams B and Adams WW III (1990) The carotenoid zeaxanthin and high-energystate quenching of chlorophyll fluorescence. Photosynth Res 25: 187-197]. In algae and plants a light-induced deepoxidation of violaxanthin to yield zeaxanthin, is related to photoprotection processes [reviewed by Demmig-Adams B and Adams WW III (1992) Photoprotection and other responses of plants to high light stress. Ann Rev Plant Physiol Plant Mol Biol 43: 599-626]. The light-induced deepoxidation of violaxanthin and the reverse reaction that takes place in the dark, are known as the "xanthophyll cycle" [see, Demmig-Adams B and Adams WW III S .(1992) Photoprotection and other responses of plants to high light stress. Ann Rev 35 Plant Physiol Plant Mol Biol 43: 599-626]. Cyanobacterial lichens, that do not contain any zeaxanthin and that probably are incapable of radiationless energy dissipation, are sensitive to high light intensity; algal lichens that contain zeaxanthin are more resistant to high-light stress [see, Demmig-Adams B, Adams WW III, Green TGA, Czygan FC and Lange OL (1990) Differences in the susceptibility to light stress in two lichens forming a phycosymbiodeme, one partner possessing and one lacking the xanthophyll cycle. Oecologia 84: 451-456: Demmig-Adams B and Adams WW III (1993) The xanthophyll cycle, protein turnover, and the high light tolerance of sun-acclimated leaves. Plant Physiol 103: 1413-1420; and, Demmig-Adams B (1990) Carotenoids and photoprotection in plants; a role for the xanthophyll zeaxanthin. Biochim Biophys Acta 1020: 1-24].
In contrast to algae and plants, cyanobacteria do not have a xanthophyll cycle.
However, they do contain ample quantities of zeaxanthin and other xanthophylls that can support photoprotection of chlorophyll.
Several other functions have been ascribed to carotenoids. The possibility that carotenoids protect against damaging species generated by near ultra-violet (UV) irradiation is suggested by results describing the accumulation of P-carotene in a UV-resistant mutant of the cyanobacterium Gloeocapsa alpicola [see, Buckley CE and Houghton JA (1976) A study of the effects of near UV radiation on the pigmentation of the blue-green alga Gloeocapsa alpicola. Arch Microbiol 107: 93- 97]. This has been demonstrated more elegantly in Escherichia coli cells that produce carotenoids [see, Tuveson RW and Sandmann G (1993) Protection by cloned carotenoid genes expressed in Escherichia coli against phototoxic molecules activated by near-ultraviolet light. Meth Enzymol 214: 323-330]. Due to their ability to quench oxygen radical species, carotenoids are efficient antioxidants and thereby protect cells from oxidative damage. This function of carotenoids is important in virtually all organisms [see, Krinsky NI (1989) Antioxidant functions of carotenoids. Free Radical Biol Med 7: 617-635; and, 25 Palozza P and Krinsky NI (1992) Antioxidant effects of carotenoids in vivo and in .vitro an overview. Meth Enzymol 213: 403-420]. Other cellular functions could be affected by carotenoids, even if indirectly. Although carotenoids in cyanobacteria are not the major photoreceptors for phototaxis, an influence of carotenoids on phototactic reactions, that have been observed in Anabaena variabilis, was attributed to the removal of singlet oxygen radicals that may act as signal intermediates in this system [see, Nultsch W and Schuchart H (1985) A model of the phototactic reaction chain of cyanobacterium Anabaena variabilis.
Arch Microbiol 142: 180-184].
In flowers and fruits carotenoids facilitate the attraction of pollinators and -35 dispersal of seeds. This latter aspect is strongly associated with agriculture. The type and degree of pigmentation in fruits and flowers are among the most important traits of many crops. This is mainly since the colors of these products 6 often determine their appeal to the consumers and thus can increase their market worth.
Carotenoids have important commercial uses as coloring agents in the food industry since they are non-toxic [see, Bauernfeind JC (1981) Carotenoids as colorants and vitamin A precursors. Academic Press, London]. The red color of the tomato fruit is provided by lycopene which accumulates during fruit ripening in chromoplasts. Tomato extracts, which contain high content (over 80% dry weight) of lycopene, are commercially produced worldwide for industrial use as food colorant. Furthermore, the flesh, feathers or eggs of fish and birds assume the color of the dietary carotenoid provided, and thus carotenoids are frequently used in dietary additives for poultry and in aquaculture. Certain cyanobacterial species, for example Spirulina sp. [see, Sommer TR, Potts WT and Morrissy NM (1990) Recent progress in processed microalgae in aquaculture. Hydrobiologia 204/205: 435-443], are cultivated in aquaculture for the production of animal and human food supplements. Consequently, the content of carotenoids, primarily of carotene, in these cyanobacteria has a major commercial implication in biotechnology.
Most carotenoids are composed of a C40 hydrocarbon backbone, constructed from eight C5 isoprenoid units and contain a series of conjugated double bonds. Carotenes do not contain oxygen atoms and are either linear or cyclized molecules containing one or two end rings. Xanthophylls are oxygenated derivatives of carotenes. Various glycosilated carotenoids and carotenoid esters have been identified. The C40 backbone can be further extended to give C45 or C50 carotenoids, or shortened yielding apocarotenoids. Some nonphotosynthetic 25 bacteria also synthesize C30 carotenoids. General background on carotenoids can be found in Goodwin TW (1980) The Biochemistry of the Carotenoids, Vol. 1, 2nd Ed. Chapman and Hall, New York; and in Goodwin TW and Britton G (1988) Distribution and analysis of carotenoids. In: Goodwin TW (ed) Plant Pigments, pp 62-132. Academic Press, New York.
More than 640 different naturally-occurring carotenoids have been so far characterized, hence, carotenoids are responsible for most of the various shades of yellow, orange and red found in microorganisms, fungi, algae, plants and animals.
Carotenoids are synthesized by all photosynthetic organisms as well as several nonphotosynthetic bacteria and fungi, however they are also widely distributed 35 through feeding throughout the animal kingdom.
Carotenoids are synthesized de novo from isoprenoid precursors only in photosynthetic organisms and some microorganisms, they typically accumulate in I* I 7 protein complexes in the photosynthetic membrane, in the cell membrane and in the cell wall.
As detailed in Figure 1, in the biosynthesis pathway of P-carotene, four enzymes convert geranylgeranyl pyrophosphate of the central isoprenoid pathway to p-carotene. Carotenoids are produced from the general isoprenoid biosynthetic pathway. While this pathway has been known for several decades, only recently, and mainly through the use of genetics and molecular biology, have some of the molecular mechanisms involved in carotenoids biogenesis, been elucidated. This is due to the fact that most of the enzymes which take part in the conversion of phytoene to carotenes and xanthophylls are labile, membrane-associated proteins that lose activity upon solubilization [see, Beyer P, Weiss G and Kleinig H (1985) Solubilization and reconstitution of the membrane-bound carotenogenic enzymes from daffodile chromoplasts. Eur J Biochem 153: 341-346; and, Bramley PM (1985) The in vitro biosynthesis of carotenoids. Adv Lipid Res 21: 243-279].
1s However, solubilization of carotenogenic enzymes from Synechocystis sp. strain PCC 6714 that retain partial activity has been reported [see. Bramley PM and Sandmann G (1987) Solubilization of carotenogenic enzyme of Aphanocapsa.
Phytochem 26: 1935-1939]. There is no genuine in vitro system for carotenoid biosynthesis which enables a direct essay of enzymatic activities. A cell-free carotenogenic system has been developed [see, Clarke IE, Sandmann G, Bramley PM and Boger P (1982) Carotene biosynthesis with isolated photosynthetic membranes. FEBS Lett 140: 203-206] and adapted for cyanobacteria [see, Sandmann G and Bramley PM (1985) Carotenoid biosynthesis by Aphanocapsa homogenates coupled to a phytoene-generating system from Phycomyces 25 blakesleeanus. Planta 164: 259-263; and, Bramley PM and Sandmann G (1985) In vitro and in vivo biosynthesis of xanthophylls by the cyanobacterium Aphanocapsa. Phytochem 24: 2919-2922]. Reconstitution of phytoene desaturase from Synechococcus sp. strain PCC 7942 in liposomes was achieved following purification of the polypeptide, that had been expressed in Escherichia coli [see, Fraser PD, Linden H and Sandmann G (1993) Purification and reactivation of recombinant Synechococcus phytoene desaturase from an overexpressing strain of Escherichia coli. Biochem J 291: 687-692].
Referring now to Figure 1, carotenoids are synthesized from isoprenoid precursors. The central pathway of isoprenoid biosynthesis may be viewed as beginning with the conversion of acetyl-CoA to mevalonic acid. D 3 -isopentenyl pyrophosphate (IPP), a C5 molecule, is formed from mevalonate and is the building block for all long-chain isoprenoids. Following isomerization of IPP to dimethylallyl pyrophosphate (DMAPP), three additional molecules of IPP are combined to yield the C20 molecule, geranylgeranyl pyrophosphate
(GGPP).
These l'-4 condensation reactions are catalyzed by prenyl transferases [see.
Kleinig H (1989) The role of plastids in. isoprenoid biosynthesis. Ann Rev Plant Physiol Plant Mol Biol 40: 39-59]. There is evidence in plants that the same enzyme. GGPP synthase, carries out all the reactions from DMAPP to GGPP [see, Dogbo O and Camara B (1987) Purification of isopentenyl pyrophosphate isomerase and geranylgeranyl pyrophosphate synthase from Capsicum chromoplasts by affinity chromatography. Biochim Biophys Acta 920: 140-148; and, Laferriere A and Beyer P (1991) Purification of geranylgeranyl diphosphate to synthase from Sinapis alba etioplasts. Biochim Biophys Acta 216: 156-163].
The first step that is specific for carotenoid biosynthesis is the head-to-head condensation of two molecules of GGPP to produce prephytoene pyrophosphate (PPPP). Following removal of the pyrophosphate, GGPP is converted to phytoene, a colorless C40 hydrocarbon molecule. This two-step reaction is catalyzed by the soluble enzyme, phytoene synthase, an enzyme encoded by a single gene (crtB), in both cyanobacteria and plants [see. Chamovitz D. Misawa N.
Sandmann G and Hirschberg J (1992) Molecular cloning and expression in Escherichia coli of a cyanobacterial gene coding for phytoene synthase, a carotenoid biosynthesis enzyme. FEBS Lett 296: 305-310; Ray JA, Bird CR, Maunders M, Grierson D and Schuch W (1987) Sequence of pTOM5, a ripening related cDNA from tomato. Nucl Acids Res 15: 10587-10588; Camara B (1993) Plant phytoene synthase complex component 3 enzymes, immunology, and biogenesis. Meth Enzymol 214: 352-365]. All the subsequent steps in the pathway occur in membranes. Four desaturation (dehydrogenation) reactions convert 25 phytoene to lycopene via phytofluene, -caroterie, and neurosporene. Each desaturation increases the number of conjugated double bonds by two such that the number of conjugated double bonds increases from three in phytoene to eleven in lycopene.
Relatively little is known about the molecular mechanism of the enzymatic dehydrogenation of phytoene [see, Jones BL and Porter JW (1986) Biosynthesis of S. carotenes in higher plants. CRC Crit Rev Plant Sci 3: 295-324; and, Beyer P, Mayer M and Kleinig H (1989) Molecular oxygen and the state of geometric iosomerism of intermediates are essential in the carotene desaturation and cyclization reactions in daffodil chromoplasts. Eur J Biochem 184: 141-150]. It 35 has been established that in cyanobacteria, algae and plants the first two desaturations, from 15-cis-phytoene to -carotene, are catalyzed by a single membrane-bound enzyme, phytoene desaturase [see, Jones BL and Porter JW (1986) Biosynthesis of carotenes in higher plants. CRC Crit Rev Plant Sci 3: 295- 324; and, Beyer P, Mayer M and Kleinig H (1989) Molecular oxygen and the state of geometric iosomerism of intermediates are essential in the carotene desaturation and cyclization reactions in daffodil chromoplasts. Eur J Biochem 184: 141-150].
Since the (-carotene product is mostly in the all-trans configuration, a cis-trans isomerization is presumed at this desaturation step. The primary structure of the phytoene desaturase polypeptide in cyanobacteria is conserved (over 65% identical residues) with that of algae and plants [see, Pecker I, Chamovitz D, Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to (-carotene is transcriptionally regulated during tomato 0o fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966; Pecker I, Chamovitz D, Mann V, Sandmann G, Boger P and Hirschberg J (1993) Molecular characterization of carotenoid biosynthesis in plants: the phytoene desaturase gene in tomato. In: Murata N (ed) Research in Photosynthesis, Vol III, pp 11-18..
Kluwer. Dordrectht]. Moreover, the same inhibitors block phytoene desaturase in is the two systems [see, Sandmann G and Boger P (1989) Inhibition of carotenoid, biosynthesis by herbicides. In: Boger P and Sandmann G (eds) Target Sites of Herbicide Action, pp 25-44. CRC Press, Boca Raton, Florida]. Consequently, it is very likely that the enzymes catalyzing the desaturation of phytoene and phytofluene in cyanobacteria and plants have similar biochemical and molecular properties, that are distinct from those of phytoene desaturases in other microorganisms. One such a difference is that phytoene desaturases from Rhodobacter capsulatus, Erwinia sp. or fungi convert phytoene to neurosporene, lycopene, or 3,4-dehydrolycopene, respectively.
Desaturation of phytoene in daffodil chromoplasts [see, Beyer P, Mayer M 25 and Kleinig H (1989) Molecular oxygen and the state of geometric iosomerism of.
intermediates are essential in the carotene desaturation and cyclization reactions in daffodil chromoplasts. Eur J Biochem 184: 141-150], as well as in a cell free system of Synechococcus sp. strain PCC 7942 [see, Sandmann G and Kowalczyk S (1989) In vitro carotenogenesis and characterization of the phytoene desaturase reaction in Anacystis. Biochem Biophys Res Com 163: 916-921], is dependent on S molecular oxygen as a possible final electron acceptor, although oxygen is not directly involved in this reaction. A mechanism of dehydrogenase-electron transferase was supported in cyanobacteria over dehydrogenation mechanism of o dehydrogenase-monooxygenase [see, Sandmann G and Kowalczyk S (1989) In 35 vitro carotenogenesis and characterization of the phytoene desaturase reaction in- Anacystis. Biochem Biophys Res Com 163: 916-921]. A conserved FAD-binding motif exists in all phytoene desaturases whose primary structures have been analyzed [see, Pecker I, Chamovitz D, Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to q-carotene is transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966; Pecker I, Chamovitz D, Mann V, Sandmann G. Boger P and Hirschberg J (1993) Molecular characterization of carotenoid biosynthesis in plants: the phytoene.desaturase gene in tomato. In: Murata N (ed) Research in Photosynthesis, Vol III, pp 11-18. Kluwer, Dordrectht]. The phytoene desaturase enzyme in pepper was shown to contain a protein-bound FAD [see. Hugueney P.
Romer S, Kuntz M and Camara B (1992) Characterization and molecular cloning of a flavoprotein catalyzing the synthesis of phytofluene and (-carotene in o1 Capsicum chromoplasts. Eur J Biochem 209: 399-407]. Since phytoene desaturase is located in the membrane, an additional, soluble redox component is predicted.
This hypothetical component could employ NAD(P) as suggested [see, Mayer MP, Nievelstein V and Beyer P (1992) Purification and characterization of a NADPH dependent oxidoreductase from chromoplasts of Narcissus pseudonarcissus a redox-mediator possibly involved in carotene desaturation.
Plant Physiol Biochem 30: 389-398] or another electron and hydrogen carrier, such as a quinone. The cellular location of phytoene desaturase in Synechocystis sp.
strain PCC 6714 and Anabaena variabilis strain ATCC 29413 was determined with specific antibodies to be mainly in the photosynthetic thylakoid membranes [see, Serrano A, Gimenez P, Schmidt A and Sandmann G (1990) Immunocytochemical localization and functional determination of phytoene desaturase in photoautotrophic prokaryotes. J Gen Microbiol 136: 2465-2469].
In cyanobacteria algae and plants -carotene is converted to lycopene via neurosporene. Very little is known about the enzymatic mechanism, which is 25 predicted to be carried out by a single enzyme [see, Linden H, Vioque A and Sandmann G (1993) Isolation of a carotenoid biosynthesis gene coding for Ccarotene desaturase from Anabaena PCC 7120 by heterologous complementation.
FEMS Microbiol Lett 106: 99-104]. The deduced amino acid sequence of C- S. carotene desaturase in Anabaena sp. strain PCC 7120 contains a dinucleotidebinding motif that is similar to the one found in phytoene desaturase.
Two cyclization reactions convert lycopene to p-carotene. Evidence has been obtained that in Synechococcus sp. strain PCC 7942 [see, Cunningham FX Jr.
Chamovitz D, Misawa N, Gantt E and Hirschberg J (1993) Cloning and functional expression in Escherichia coli of a cyanobacterial gene for lycopene cyclase, the 35 enzyme that catalyzes the biosynthesis of p-carotene. FEBS Lett 328: 130-138], as well as in plants [see, Camara B and Dogbo O (1986) Demonstration and solubilization of lycopene cyclase from Capsicum chromoplast membranes. Plant Physiol 80:' 172-184], these two cyclizations are catalyzed by a single enzyme.
lycopene cyclase. This membrane-bound enzyme is inhibited by the triethylaminc compounds, CPTA and MPTA [see, Sandmann G and Boger P (1989) Inhibition of carotenoid biosynthesis by herbicides. In: Boger P and Sandmann G (eds) Target Sites of Herbicide Action, pp 25-44. CRC Press, Boca Raton, Florida].
Cyanobacteria carry out only the P-cyclization and therefore do not contain Ecarotene, 8-carotene and a-carotene and their oxygenated derivatives. The p-ring is formed through the formation-of a "carbonium ion" intermediate when the C-1,2 double bond at the end of the linear lycopene molecule is folded into the position of the C-5,6 double bond, followed by a loss of a proton from C-6. No cyclic carotene has been reported in which the 7,8 bond is not a double bond. Therefore.
full desaturation as in lycopene, or desaturation of at least half-molecule as in neurosporene, is essential for the reaction. Cyclization of lycopene involves a dehydrogenation reaction that does not require oxygen. The cofactor for this reaction is unknown. A dinucleotide-binding domain was found in the lycopene is cyclase polypeptide of Synechococcus sp. strain PCC 7942, implicating NAD(P) or FAD as coenzymes with lycopene cyclase.
The addition of various oxygen-containing side groups, such as hydroxy-, methoxy-, oxo-, epoxy-, aldehyde or carboxylic acid moieties, form the various xanthophyll species. Little is known about the formation of xanthophylls.
Hydroxylation of p-carotene requires molecular oxygen in a mixed-function oxidase reaction.
Clusters of genes encoding the enzymes for the entire pathway have been cloned from the purple photosynthetic bacterium Rhodobacter capsulatus [see, Armstrong GA, Alberti M, Leach F and Hearst JE (1989) Nucleotide sequence, 25 organization, and nature of the protein products of the carotenoid biosynthesis gene cluster of Rhodobacter capsulatus. Mol Gen Genet 216: 254-268] and from the nonphotosynthetic bacteria Erwinia herbicola [see, Sandmann G, Woods WS and Tuveson RW (1990) Identification of carotenoids in Erwinia herbicola and in transformed Escherichia coli strain. FEMS Microbiol Lett 71: 77-82: Hundle BS, Beyer P, Kleinig H, Englert H and Hearst JE (1991) Carotenoids of Erwinia herbicola and an Escherichia coli HB101 strain carrying the Erwinia herbicola se.* carotenoid gene cluster. Photochem Photobiol 54: 89-93; and, Schnurr G, Schmidt A and Sandmann G (1991) Mapping of a carotenogenic gene cluster from Erwinia *herbicola and functional identification of six genes. FEMS Microbiol Lett 78: 157- 35 162] and Erwinia uredovora [see, Misawa N, Nakagawa M, Kobayashi K; Yamano S, Izawa I, Nakamura K and Harashima K (1990) Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products in Escherichia coli. J Bacteriol 172: 6704-6712]. Two genes, al-3 for GGPP synthase [see, Nelson MA, Morelli G, Carattoli A, Romano N and Macino G (1989) Molecular cloning of a Neurospora crassa carotenoid biosynthetic gene (albino-3) regulated by blue light and the products of the white collar genes. Mol Cell Biol 9: 1271-1276; and, Carattoli A, Romano N, Ballario P Morelli G and Macino G (1991) The Neurospora crassa carotenoid biosynthetic gene (albino J Biol Chem 266: 5854-5859] and al-I for phytoene desaturase [see. Schmidhauser TJ, Lauter FR, Russo VEA and Yanofsky C (1990) Cloning sequencing and photoregulation of al-1, a carotenoid biosynthetic gene of Neurospora crassa. Mol Cell Biol 10: 5064-5070] have been cloned from the fungus Neurospora crassa. However, attempts at using these genes as heterologous molecular probes to clone the corresponding genes from cyanobacteria or plants were unsuccessful due to lack of sufficient sequence similarity.
The first "plant-type" genes for carotenoid synthesis enzyme were cloned from cyanobacteria using a molecular-genetics approach. In the first step towards cloning the gene for phytoene desaturase, a number of mutants that are resistant to the phytoene-desaturase-specific inhibitor, norflurazon, were isolated in Synechococcus sp. strain PCC 7942 [see, Linden H, Sandmann G, Chamovitz D, Hirschberg J and Boger P (1990) Biochemical characterization of Synechococcus S 20 mutants selected against the bleaching herbicide norflurazon. Pestic Biochem Physiol 36: 46-51]. The gene conferring norflurazon-resistance was then cloned y transforming the wild-type strain to herbicide resistance [see, Chamovitz D, ecker I and Hirschberg J (1991) The molecular basis of resistance to the herbicide norflurazon. Plant Mol Biol 16: 967-974; Chamovitz D, Pecker I, Sandmann G, Boger P and Hirschberg J (1990) Cloning a gene for norflurazon resistance in cyanobacteria. Z Naturforsch 45c: 482-486]. Several lines of evidence indicated that the cloned gene, formerly called pds and now named crtP, codes for phytoene desaturase. The most definitive one was the functional expression of phytoene desaturase activity in transformed Escherichia coli cells [see, Linden H, Misawa 30 N, Chamovitz D, Pecker I, Hirschberg J and Sandmann G (1991) Functional complementation in Escherichia coli of different phytoene desaturase genes and analysis of accumulated carotenes. .Z Naturforsch 46c: 1045-1051; and. Pecker 1, Chamovitz D, Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to (-carotene is transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966]. The crtP gene was also cloned from Synechocystis sp. strain PCC 6803 by similar methods [see, Martinez-Ferez IM and Vioque A (1992) Nucleotide sequence of the phytoene desaturase gene from Synechocystis sp. PCC 6803 and characterization of a new mutation which confers resistance to the herbicide norflurazon. Plant Mol Biol 18: 981-983].
The cyanobacterial crtP gene was subsequently used as a molecular probe for cloning the homologous gene from an alga [see. Pecker I, Chamovitz D. Mann V. Sandmann G, Boger P and Hirschberg J (1993) Molecular characterization of carotenoid biosynthesis in plants: the phytoene desaturase gene in tomato. In: Murata N (ed) Research in Photosynthesis, Vol III, pp 11-18. Kluwer, Dordrectht] and higher plants [see, Bartley GE, Viitanen PV, Pecker I, Chamovitz D, Hirschberg J and Scolnik PA (1991) Molecular cloning and expression in photosynthetic bacteria of a soybean cDNA coding for phytoene desaturase, an enzyme of the carotenoid biosynthesis pathway. Proc Natl Acad Sci USA 88: 6532-6536; and, Pecker I, Chamovitz D, Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to -carotene is transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966]. The phytoene desaturases in Synechococcus sp. strain PCC 7942 and Synechocystis sp. strain PCC 6803 consist of 474 and 467 amino acid residues, respectively, whose sequences are highly conserved (74% identities and 86% similarities). The calculated molecular mass is 51 kDa and, although it is slightly hydrophobic (hydropathy index it does not include a hydrophobic region 20 which is long enough to span a lipid bilayer membrane. The primary structure of the cyanobacterial phytoene desaturase is highly conserved with the enzyme from the green alga Dunalliela bardawil (61% identical and 81% similar; [see, Pecker I, Chamovitz D, Mann V, Sandmann G, Boger P and Hirschberg J (1993) Molecular characterization of carotenoid biosynthesis in plants: the phytoene desaturase gene in tomato. In: Murata N (ed) Research in Photosynthesis, Vol III, pp 11-18.
Kluwer, Dordrectht]) and from tomato- [see, Pecker I, Chamovitz D. Linden H, S. Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to C-carotene is transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966], pepper [see, Hugueney P, Romer S, Kuntz M and Camara B (1992) Characterization and molecular cloning of a flavoprotein catalyzing the synthesis of phytofluene and -carotene in Capsicum chromoplasts. Eur J Biochem 209: 399-407] and soybean [see, Bartley GE, Viitanen PV, Pecker I, Chamovitz D, Hirschberg J and Scolnik PA (1991) Molecular cloning and expression in photosynthetic bacteria of a soybean cDNA coding for phytoene desaturase, an enzyme of the carotenoid biosynthesis pathway. Proc Natl Acad Sci USA 88: 6532-6536] (62-65% identical and -79% similar; [see, Chamovitz D (1993) Molecular analysis of the early steps of carotenoid biosynthesis in cyanobacteria: Phytoene synthase and phytoene desaturase. Ph.D. Thesis, The Hebrew University of Jerusalem]). The eukaryotic phytoene desaturase polypeptides are larger (64 kDa); however, they are processed during import into the plastids to mature forms whose sizes are comparable to those of the cyanobacterial enzymes.
There is a high degree of structural similarity in carotenoid enzymes of Rhodobacter capsulatus, Erwinia sp. and Neurospora crassa [reviewed in Armstrong GA, Hundle BS and Hearst JE (1993) Evolutionary conservation and structural similarities of carotenoid biosynthesis gene products from photosynthetic and nonphotosynthetic organisms. Meth Enzymol 214: 297-311], to including in the crtI gene-product, phytoene desaturase. As indicated above, a high degree of conservation of the primary structure of phytoene desaturases also exists among oxygenic photosynthetic organisms. However, there is little sequence similarity, except for the FAD binding sequences at the amino termini, between the "plant-type" crtP gene products and the ."bacterial-type" phytoene desaturases (crtl gene products; 19-23% identities and 42-47% similarities). It has been hypothesized that crtP and crtI are not derived from the same ancestral gene and that they originated independently through convergent evolution [see, Pecker I, Chamovitz D, Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to C-carotene is 20 transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966]. This hypothesis is supported by the different dehydrogenation sequences that are catalyzed by the two types of enzymes and by their different sensitivities to inhibitors.
Although not as definite as in the case of phytoene desaturase, a similar distinction between cyanobacteria and plants on the one hand and other microorganisms is also seen in the structure of phytoene synthase. The crtB gene (formerly psy) encoding phytoene synthase was identified in the genome of Synechococcus sp. strain PCC 7942 adjacent to crtP and within the same operon [see, Bartley GE, Viitanen PV, Pecker I, Chamovitz D, Hirschberg J and Scolnik 30 PA (1991) Molecular cloning and expression in photosynthetic bacteria of a soybean cDNA coding for phytoene desaturase, an enzyme of the carotenoid biosynthesis pathway. Proc Natl Acad Sci USA 88: 6532-6536]. This gene S encodes a 36-kDa polypeptide of 307 amino acids with a hydrophobic index of 0.4. The deduced amino acid sequence of the cyanobacterial phytoene synthase is highly conserved with the tomato phytoene synthase (57% identical and similar: Ray JA, Bird CR, Maunders M, Grierson D and Schuch W (1987) Sequence of pTOM5, a ripening related cDNA from tomato. Nucl Acids Res 10587-10588]) but is less highly conserved with the crtB sequences from other bacteria (29-32% identical and 48-50% similar with ten gaps in the alignment).
Both types of enzymes contain two conserved sequence motifs also found in prenyl .transferases from diverse organisms [see, Bartley GE, Viitanen PV, Pecker 1. Chamovitz D, Hirschberg J and Scolnik PA (1991) Molecular cloning and expression in photosynthetic bacteria of a soybean cDNA coding for phytoene desaturase, an enzyme of the carotenoid biosynthesis pathway. Proc Natl Acad Sci USA 88: 6532-6536; Carattoli A, Romano N, Ballario P, Morelli G and:Macino G (1991) The Neurospora crassa carotenoid biosynthetic gene (albino J Biol Chem 266: 5854-5859; Armstrong GA, Hundle BS and Hearst JE (1993) Evolutionary conservation and structural similarities of carotenoid biosynthesis gene products from photosynthetic and nonphotosynthetic organisms. Meth Enzymol 214: 297-311; Math SK, Hearst JE and Poulter CD (1992) The crtE gene in Erwinia herbicola encodes geranylgeranyl diphosphate synthase. Proc Nat! Acad Sci USA 89: 6761-6764; and, Chamovitz D (1993) Molecular analysis of the.
s1 early steps of carotenoid biosynthesis in cyanobacteria: Phytoene synthase and phytoene desaturase. Ph.D. Thesis, The Hebrew University of Jerusalem]. It is conceivable that these regions in the polypeptide are involved in the binding and/or removal of the pyrophosphate during the condensation of two GGPP molecules.
The crtQ gene encoding (-carotene desaturase (formerly zds) was cloned 20 from Anabaena sp. strain PCC 7120 by screening an expression library of cyanobacterial genomic DNA in cells of Escherichia coli carrying the Erwinia sp.
crtB and crtE genes and the cyanobacterial crtP gene [see, Linden H, Vioque A and Sandmann G (1993) Isolation of a carotenoid biosynthesis gene coding for Ccarotene desaturase from Anabaena PCC 7120 by heterologous complementation.
FEMS Microbiol Lett 106: 99-104]. Since these Escherichia coli cells produce Ci carotene, brownish-red pigmented colonies that produced lycopene could be identified on the yellowish background of cells producing (-carotene. The predict&d c-carotene desaturase from Anabaena sp. strain PCC 7120 is a 56-kDa polypeptide which consists of 499 amino acid residues. Surprisingly, its primary 30 structure is not conserved with the "plant-type" (crtP gene product) phytoene desaturases, but it has considerable sequence similarity to the bacterial-type enzyme (crtI gene product) [see, Saridmann G (1993) Genes and enzymes involved in the desaturation reactions from phytoene to lycopene. (abstract), International Symposium on Carotenoids, Trondheim CL1-2]. It is possible that the cyanobacterial crtQ gene and crtl gene of other microorganisms originated in evolution from a common ancestor.
The crtL gene for lycopene cyclase (formerly Icy) was cloned from Synechococcus sp. strain PCC 7942 utilizing essentially the same cloning strategy as for crtP. By using an inhibitor of lycopene cyclase, 2 4 -methylphenoxy)triethylamine hydrochloride (MPTA), the gene was isolated by transformation of the wild-type to herbicide-resistance [see, Cunningham FX Jr, Chamovitz
D.
Misawa N, Gantt E and Hirschberg J (1993) Cloning and functional expression in Escherichia coli of a cyanobacterial gene for lycopene cyclase. the enzyme that catalyzes the biosynthesis of -carotene. FEBS Lett 328: 130-138]. Lycopene cyclase is the product of a single gene product and catalyzes the double cyclization reaction of lycopene to P-carotene. The crtL gene product in Synechococcus sp.
strain PCC 7942 is a 46-kDa polypeptide of 411 amino acid residues. It has no sequence similarity to the crtY gene product (lycopene cyclase) from Erwinia uredovora or Erwinia herbicola.
The gene for p-carotene hydroxylase (crtZ) and zeaxanthin glycosilase (crtX) have been cloned from Erwinia herbicola [see, Hundle B, Alberti M, Nievelstein V, Beyer P, Kleinig H, Armstrong GA, Burke DH and Hearst JE (1994) Functional assignment of Erwinia herbicola EholO carotenoid genes expressed in Escherichia coli. Mol Gen Genet 254: 406-416; Hundle BS, Obrien DA, Alberti M, Beyer P and Hearst JE (1992) Functional expression of zeaxanthin glucosyltransferase from Erwinia herbicola and a proposed diphosphate binding site. Proc Natl Acad Sci USA 89: 9321-9325] and from Erwinia uredovora [see.
Misawa N, Nakagawa M, Kobayashi K, Yamano S, Izawa I, Nakamura K and Harashima K (1990) Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products in Escherichia coli. J Bacteriol 172: 6704-6712].
The ketocarotenoid astaxanthin (3,3'-dihydroxy-P, -carotene-4,4'-dione) was first described in aquatic crustaceans as an oxidized form of P-carotene.
Astaxanthin was later found to be very common in many marine animals and algae. However, only few animals can synthesize astaxanthin de novo from other carotenoids and most of them obtain it in their food. In the plant kingdom, astaxanthin occurs mainly in some species of cyanobacteria, algae and lichens.
30 However, it is found rarely also in petals of higher plant species [see, Goodwin TW (1980) The Biochemistry of the carotenoids, Vol. 1. 2nd Ed, Chapman and Hall, London and New York].
The function of astaxanthin as a powerful antioxidant in animals has been demonstrated [see, Miki W (1991) Biological functions and activities of animal carotenoids. Pure Appl Chem 63: 141]. Astaxanthin is a strong inhibitor of lipid peroxidation and has been shown to play an active role in the protection of biological membranes from oxidative injury [see, Palozza P and Krinsky NI (1992) Antioxidant effects of carotenoids in vivo and in vitro an overview. Methods Enzymol 213: 403-420; and, Kurashige M, Okimasu E, Inove M and Utsumi K (1990) Inhibition of oxidative injury of biological membranes by astaxanthin.
Physiol Chem Phys Med NMR 22: 27]. The chemopreventive effects of astaxanthin have also been investigated in which astaxanthin was shown to significantly reduce the incidence of induced urinary bladder cancer in mice [see.
Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A. and Mori H (1994).
Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15: 15]. It has also been demonstrated that astaxanthin exerts immunomodulating effects by enhancing o1 antibody production [see, Jyonouchi H, Zhang L and Tomita Y (1993) Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer 19: 269; and, Jyonouchi H, Hill JR, Yoshifumi T and Good RA (1991) Studies of irfmunomodulating actions of carotenoids. I. Effects of P-carotene and astaxanthin on murine lymphocyte functions and cell surface marker expression in-vitro culture system. Nutr Cancer 16: 93]. The complete biomedical properties of astaxanthin remain to be elucidated, but initial results suggest that it could play an important role in cancer and tumor prevention, as well as eliciting a positive response from the immune system.
S. 20 Astaxanthin is the principal carotenoid pigment of salmonids and shrimps and imparts attractive pigmentation in the eggs, flesh and skin [see, Torrisen OJ, Hardy RW, Shearer KD (1989) Pigmentation of salmonid-carotenoid deposition and metabolism in salmonids. Crit Rev Aquatic Sci 1: 209]. The world-wide harvest of salmon in 1991 was approximately 720,000 MT.. of which 25-30% were produced in a variety of aquaculture facilities [see, Meyers SP (1994) Developments in world aquaculture, feed formulations, and role of carotenoids.
Pure Appl Chem 66: 1069]. This is set to increase up to 460,000 MT. by the year 2000 [see, Bjorndahl T (1990) The Economics of Salmon Aquaculture. Blackwell Scientific, Oxford. pp. The red coloration of the salmonid flesh contributes to 30 consumer appeal and therefore affects the price of the final product. Animals cannot synthesize carotenoids and they acquire the pigments through the food chain from the primary producers marine algae and phytoplankton. Those grown in intensive culture usually suffer from suboptimal color. Consequently, carotenoid-containing nourishment is artificially added in aquaculture, at considerable cost to the producer.
Astaxanthin is the most expensive commercially used carotenoid compound (todays-1995 market value is of 2,500-3,500 It is utilized mainly as nutritional supplement which provides pigmentation in a wide variety of aquatic 18 animals. In the Far-East it is used also for feeding poultry to yield a typical pigmentation of chickens. It is also a desirable and effective nontoxic coloring for the food industry and is valuable in cosmetics. Recently it was reported that astaxanthin is a potent antioxidant in humans and thus is a desirable food additive.
Natural (3S,3'S) astaxanthin is limited in availability. It is commercially extracted from some crustacea species [see, Torrisen OJ, Hardy RW, Shearer KD (1989) Pigmentation of salmohid-carotenoid deposition and metabolism in salmonids. Crit Rev Aquatic Sci 1: 209]. The (3R,3'R) stereoisomer of astaxanthin is produced from Phaffia [a yeast specie, see, Andrewes AG, Phaff HJ and Starr MP (1976) Carotenoids of Phaffia rhodozyma. a red-pigmented fermenting yeast. Phytochemistry Vol. 15, pp. 1003-1007]. Synthetic astaxanthin.
comprising a 1:2:1 mixture of the and (3R,3'R)-isomers is now manufactured by Hoffman-La Roche and sold at a high price (ca. $2,500/Kg) under the name "CAROPHYLL Pink" [see, Mayer H (1994) Reflections on carotenoid synthesis. Pure Appl Chem, Vol. 66, pp. 931-938]. Recently a novel gene involved in ketocompound biosynthesis, designated crtW was isolated from the marine bacteria Agrobacterium auranticacum and Alcaligenes PC-I that produce ketocarotenoids such as astaxanthin. When the crtW gene was introduced into 'engineered Eschrichia coli that accumulated p-carotene due to Erwinia carotenogenic genes, the Escherichia coli transformants synthesized canthaxanthin a precursor in the synthetic pathway of astaxanthin [see, Misawa N, Kajiwara S, Kondo K, Yokoyama A, Satomi Y, Saito T, Miki W and Ohtani T (1995) Canthaxanthin biosynthesis by the conversion of methylene to keto groups in a S hydrocarbon p-carotene by a single gene. Biochemical and biophysical research communications Vol. 209, pp. 867-876]. It is therefore desirable to find a relatively inexpensive source of (3S,3'S) astaxanthin to be used as a feed supplement in aquaculture and as a valuable chemical for various other industrial uses.- Although astaxanthin is synthesized in a variety of bacteria, fungi and algae, 30 the key limitation to the use of biological systems for its production is the low yield of and costly extraction methods in these systems compared to chemical synthesis. One way to solve these problems is to increase the productivity of astaxanthin production in biological systems using recombinant DNA technology.
This allows for the production of astaxanthin in genetically engineered host which.
in the case of a higher plant, is easy to grow and simple to extract. Furthermore.
production of astaxanthin in genetically engineered host enables by appropriate host selection to use thus produced astaxanthin in for example aquaculture applications, devoid of the need for extraction.
19- There is thus a widely recognised need for, and it would be highly advantageous to have, a nucleic acid segment which encodes P-C-4-oxygenase, the enzyme that converts p-carotene to canthaxanthin, as well as recombinant vector molecules comprising a nucleic acid sequence according to the invention, and host cells or transgenic organisms transformed or transfected with these vector molecules or DNA segment for the biotechnological production of (3S, 3'S) astaxanthin.
Other features and advantages of the invention will be apparent from the following description and from the claims.
All references, including any patents or patent applications, cited in this specification are hereby incorporated by reference. No admission is made that any reference constitutes prior art. The discussion of the references states what their authors assert, and the applicants reserve the right to challenge the accuracy and pertinency of the cited documents. It will be clearly understood that, although a number of prior art publications are referred to herein, this reference does not constitute an admission that any of these documents forms part of the common general knowledge in the art, in Australia or in any other country.
In the claims which follow and in the description of the invention, except where the context requires otherwise due to express language or necessary S"implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, S" 30 i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention.
SUMMARY OF THE INVENTION 35 The present invention provides a method of controlling carotenoid production in a chromoplast and/or chloroplast containing tissue of a plant, the method H\RBe11\Keep\57796-1dC /12/03 H,\ell\Keep\57796-01.doc /12/03 20 comprising modulating an activity of p-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue, said P-C-4-oxygenase having an amino acid sequence at least identical to SEQ ID NO:4, thereby controlling carotenoid production in said chromoplast and/or chloroplast containing tissue of said plant.
The present invention further provides a plant overexpressing a recombinant P-C-4-oxygenase in chromoplasts and/or chloroplasts of chromoplasts and/or chloroplasts containing tissue of said plant, as compared to a wild type plant, said recombinant P-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO: 4.
The present invention further provides a plant underexpressing a recombinant P-C-4-oxygenase in chromoplasts and/or chloroplasts of chromoplasts and/or chloroplasts containing tissue of said plant, as compared to a wild type plant, said recombinant p-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO: 4.
The present invention further provides a biotechnological method for production of (3S, 3'S) astaxanthin.
The invention further provides a peptide having a p-C-4-oxygenase activity and a DNA segment coding for this peptide to enable a biotechnological production of Sastaxanthin and other xanthophylls.
The invention further provides an RNA segment coding for a polypeptide comprising an amino acid sequence 30 corresponding to above described peptide.
The invention further provides a recombinant DNA molecule comprising a vector and the DNA segment as described above.
The invention further provides a host cell 35 containing the above described recombinant DNA molecule.
He\RBell\Keep\57796-01.doc 2/12/03 20a The invention further provides a host transgenic organism containing the above described recombinant DNA molecule or the above described DNA segment in its cells.
The invention further provides a host transgenic organism which expresses P-C-4-oxygenase activity in cholorplasts and/or chromoplasts-containing tissues.
The invention further provides a food additive for animal or human consumption comprising the above described host cell or transgenic organism.
The invention further provides a method of producing astaxanthin using the above described host cell or transgenic organism.
The invention further provides a method of producing canthaxanthin, echinenone, cryptoxanthin, isocryptoxanthin hydroxyechinenone, zeaxanthin, adonirubin, and/or adonixanthin using the above described host cell or transgenic organism.
Further embodiments and advantages of the present invention will be clear from the description that follows.
In one embodiment, the present invention relates to a DNA segment coding for a polypeptide comprising an amino acid sequence corresponding to a Haematococcus pluvialis crtO gene.
In a further embodiment, the present invention 25 relates to an RNA segment coding for a polypeptide comprising an amino acid sequence corresponding to a Haematococcus pluvialis crtO gene.
In yet another embodiment, the present invention relates to a polypeptide comprising an amino acid sequence 30 corresponding to a Haematococcus pluvialis crtO gene.
In a further embodiment, the present invention relates to a recombinant DNA molecule comprising a vector and a DNA segment coding for a polypeptide, corresponding to a Haematococcus pluvialis crtO gene.
e \Keep\7796-01 2/12/03 Hi\Rell\Keep\57796-Ol.doc 2/12/03 20b In another embodiment, the present invention relates to a host cell containing the above described recombinant DNA molecule or DNA segment.
In a further embodiment, the present invention relates to a host transgenic organism containing the above described recombinant DNA molecule or the above described DNA segment in its cells.
In another embodiment, the present invention relates to a method of producing astaxanthin using the above described host cell or transgenic organism.
In yet another embodiment, the present invention relates to a method of producing other xanthophylls.
In still another embodiment, the present invention relates to a method of obtaining high expression of a transgene in plants specifically in chromoplastscontaining cells.
In one further embodiment, the present invention relates to a method of importing a carotenoid-biosynthesis enzyme encoded by a transgene into chromoplasts.
BRIEF DESCRIPTION OF THE DRAWINGS The invention is herein described, by way of example only, with reference to the accompanying drawings, wherein: 25 FIG. 1 is a general biochemical pathway of Pcarotene biosynthesis, in which pathway all molecules are depicted in an all-trans configuration, wherein IPP is isopentenyl pyrophosphate, DMAPP is dimethylallyl S"pyrophosphate, GPP is geranyl pyrophosphate, FPP is 30 farnesyl pyrophosphate, GGPP is geranylgeranyl pyrophosphate and, PPPP is prephytoene pyrophosphate; *H;\Re\Keep\ 2/12/03 H:\RBell\Keep\57796-01.doc 2/12/03 21 FIG. 2 is an identity map between the nucleotide sequence of the crtO cDNA of the present invention (CRTOA.SEQ) and the cDNA cloned by Kajiwara et al.. (CRTOJ.SEQ) [see, Kajiwara S, Kakizono T, Saito T, Kondo K. Ohtani T.
Nishio N, Nagai S and Misawa N (1995) Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli. Plant Molec Biol 29: 343-352], using a GCG software, wherein indicate identity, indicate a gap and nucleotides numbering is according to SEQ ID NO:4 for CRTOA.AMI and Kajiwara et al., for
CRTOJ.AMI;
FIG. 3 is an identity map between the amino acid sequence encoded by the crtO cDNA of the present invention (CRTOA.AMI) and the amino acid sequence encoded by the cDNA cloned by Kajiwara et al., (CRTOJ.AMI) [see, Kajiwara S, Kakizono T, Saito T, Kondo K, Ohtani T, Nishio N, Nagai S and Misawa N (1995) Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli. Plant Molec Biol 29: 343-352], using a GCG software, wherein indicate identity, indicate a gap and amino acids numbering is according to SEQ ID NO:4 for CRTOA.AMI and Kajiwara et al., for CRTOJ.AMI; FIG. 4 is a schematic depiction of a pACYC 184 derived plasmid designated pBCAR and includes the genes crtE, crtB, crtI and crtY of Erwinia herbicola, which genes are required for production of p-carotene in Escherichia coli cells; FIG. 5 is a schematic depiction of a pACYC184 derived plasmid designated pZEAX and includes the genes crtE, crtB, crtI, crtY and crtZ from Erwinia herbicola, which genes are required for production of zeaxanthin in Escherichia coli cells; FIG. 6 is a schematic depiction of a pBluescriptSK- derived plasmid designated pHPK, containing a full length cDNA insert encoding a P-carotene C- 4-oxygenase enzyme frori Haematococcus pluvialis, designated crtO and set forth in SEQ ID NO:1, which cDNA was identified by color complementation of 30 Escherichia coli cells; FIG. 7 is a schematic depiction of a pACYC 184 derived plasmid designated pCANTHA which was derived by inserting a 1.2 kb PstI-PstI DNA fragment.
containing the cDNA encoding the p-C-4-oxygenase from Haematococcus pluvialis isolated from the plasmid pHPK of Figure 6 and inserted into a PstI site in the coding sequence of the crtZ gene in the plasmid pZEAX of Figure 5; this recombinant plasmid carries the genes crtE, crtB, crtl, crtY of Erwinia herbicola and the crtO gene of Haematococcus pluvialis, all required for production of canthaxanthin in Escherichia coli cells; FIG. 8 is a schematic depiction of a pACYC184 derived plasmid designated pASTA which was derived by inserting the 1.2 kb Pstl-Pstl DNA fragment, containing the cDNA of the p-C-4-oxygenase from. Haematococcus pluvialis isolated from the plasmid pHPK of Figure 6 and inserted into a PstI site which exists 600 bp downstream of the crtE gene in the plasmid pZEAX of Figure 5; this recombinant plasmid carries the genes crtE, crtB, crtl, crtY, crtZ of Erwinia herbicola and the crtO gene of Haematococcus pluvialis, all required for production of astaxanthin in Escherichia coli cells; FIG. 9 is a schematic depiction of a pBR328 derived plasmid designated PAN3.5-KETO which was derived by inserting the 1.2 kb Pstl-PstI DNA fragment, containing the cDNA of the p-C-4-oxygenase from Haematococcus pluvialis isolated from the plasmid pHPK of Figure 6 and inserted into a Pstl site which exists in a p-lactamase gene in a plasmid designated pPAN35D5 [described in Hirschberg J, Ohad N, Pecker I and Rahat A (1987) Isolation and characterization of herbicide resistant mutants in the cyanobacterium Synechococcus R2. Z. Naturforsch 42c: 102-112], which carries the psbAl gene from the cyanobacterium Synechococcus PCC7942 in the plasmid vector pBR328 [see, Hirschberg J, Ohad N, Pecker I and Rahat A (1987) Isolation and characterization of herbicide resistant mutants in the cyanobacterium Synechococcus R2. Z. Naturforsch 42c: 102-112]; this recombinant plasmid carries the crtO gene of Haematococcus pluvialis, required for production of astaxanthin in Synechococcus PCC7942 cells; FIG. 10 is a schematic depiction of the T-DNA region of a Ti binary plasmid coli, Agrobacterium) designated pBIB [described by Becker D 25 (1990) Binary vectors which allow the exchange of plant selectable markers and reporter genes. Nucleic Acids Research 18:230] which is a derivative of the Ti plasmid pBI101 [described by Jeffesrson AR, Kavanagh TA and Bevan WM (1987) GUS fusions: P-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. The EMBO J. 6: 3901-3907], wherein BR and BL are the right and left borders, respectively, of the T-DNA region, pAg7 is the polyadenylation site of gene 7 ofAgrobacterium Ti-plasmid, pAnos is. a 250 bp long DNA fragment containing the poly adenylation site of the nopaline synthase gene of Agrobacterium, NPT II is a 1,800 bp long DNA fragment coding for kanamycin resistance, pnos is a 300 bp long DNA fragment containing the promoter sequence of the nopaline synthase gene of Agrobacterium, whereas pAnos is a 300 bp long DNA fragment containing the poly adenylation site of the nopaline synthase gene of Agrobacterium: 23 FIG. 11 is a schematic depiction of the T-DNA region of a Ti binary plasmid coli, Agrobacterium) designated pPTBIB which was prepared by cloning a genomic DNA sequence of a tomato species Lycopersicon esculentum marked PT (nucleotides 1 to 1448 of the Pds gene as published in Mann V. Pecker I and Hirschberg J (1994) cloning and characterization of the gene for phytoene desaturase (Pds) from tomato (Lycopersicon esculentum).
Plant Molecular Biology 24: 429-434), which contains the promoter of the Pds gene and the coding sequence for the amino terminus region of the polypeptide PDS that serve as a transit peptide for import into chloroplasts and o0 chromoplasts, into a HindIII-SmaI site of the binary plasmid vector pBIB of Figure 10, wherein BR and BL, pAg7, pAnos, NPT II, pnos and pAnos are as defined above; FIG. 12 is a schematic depiction of the T-DNA region of a Ti binary plasmid coli, Agrobacterium) designated pPTCRTOBIB which was prepared by cloning a 1,110 nucleotide long, Eco471II-Nco fragment of the cDNA of crtO from H. pluvialis (nucleotides 211 to 1321 of SEQ ID NO:1) into the Snma site of the plasmid pPTBIB of Figure 11, such that the coding nucleotide sequence of the amino terminus of PDS is in the same reading frame of crtO, wherein BR and BL, pAg7, pAnos, NPT II, pnos, and pAnos are as defined above, PT is the promoter and transit peptide coding sequences of Pds from tomato and CRTO is the nucleotide sequence of crtO from H. pluvialis .(nucleotides 211 to 1321 of SEQ ID NO:1); FIG. 13 shows a Southern DNA blot analysis of HindIII-digested genomic DNA extracted from wild type (WT) and crtO tobacco transgenic plants, 25 designated 2, 3, 4, 6, 9 and 10, according to the present invention, using the'crtO cDNA as a radioactive probe, essentially as described in Sambrook et al., SMolecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1989, wherein the size of marker DNA fragments in kilobase pairs (kb) is indicated on the left as well as the expected position (arrow) of an internal T-DNA HindIII fragment as was deduced from the sequence of pPTPDSBIB shown in Figure 12 which contain the crtO cDNA sequence; SFIG. 14 shows a biosynthesis pathway of astaxanthin; FIG. 15 shows a flower from a wild type tobacco plant and a flower from a transgenic tobacco plant according to the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention is, in general, of a biotechnological method for production of (3S,3'S) astaxanthin. In particular, the present invention is of a 24 peptide having a P-C-4-oxygenase activity; a DNA segment coding for this peptide; an RNA segments coding for this peptide; a recombinant DNA molecule comprising a vector and the DNA segment; a host cell or organism containing the above described recombinant DNA molecule or DNA segment; and of a method for biotechnologically producing (3S,3'S) astaxanthin or a food additive containing (3S.3'S) astaxanthin, using the host.
The unicellular fresh-water green alga Haematococcus pluvialis accumulates large amounts of (3S,3'S) astaxanthin when exposed to unfavorable growth conditions, or following different environmental stresses such as phosphate o0 or nitrogen starvation, high concentration of salt in the growth medium or high light intensity [see, Yong YYR and Lee YK (1991) Phycologia 30 257-261; Droop MR (1954) Arch Microbiol 20: 391-397; and, Andrewes A.G, Borch G, Liaaen- Jensen S and Snatzke G.(1974) Acta Chem Scand B28: 730-736]. During this process, the vegetative cells -of the alga form cysts and change their color from green to red. The present, invention discloses the cloning of a cDNA fron Haematococcus pluvialis, designated crtO, which encodes a p-C-4-oxygenase. the enzyme that converts p-carotene to canthaxanthin, and its expression in a heterologous systems expressing p-carotene hydroxylase Erwinia herbicola crtZ gene product), leading to the production of(3S,3'S) astaxanthin.
The crtO cDNA and its encoded peptide having a p-C-4-oxygenase activity are novel nucleic and amino acid sequences, respectively. The cloning method of the crtO cDNA took advantage of a strain of Escherichia coli. which was genetically engineered to produce p-carotene, to which a cDNA library of Haematococcus pluvialis was transfected and expressed. Visual screening for 25 brown-red pigmented Escherichia coli cells has identified a canthaxanthin producing transformant. Thus cloned cDNA has been expressed in two heterologous systems (Escherichia coli and Synechococcus PCC7942 cells) both able to produce P-carotene and further include an engineered (Erwinia herbicola crtZ gene product) or endogenous P-carotene hydroxylase activity, and was shown 30 to enable the production of(3S,3'S) astaxanthin in both these systems.
The crtO cDNA or its protein product exhibit no meaningful nucleic- or amino acid sequence similarities to the nucleic- or amino acid sequence of crtW and its protein product isolated from the marine bacteria Agrobacterium auranticacum and Alcaligenes PC-1 that produce ketocarotenoids such as astaxanthin [see, Misawa N, Kajiwara S, Kondo K, Yokoyama A, Satomi Y, Saito T, Miki W and Ohtani T (1995) Canthaxanthin biosynthesis by the conversion of methylene to keto groups in a hydrocarbon P-carotene by a single gene.
Biochemical and biophysical research communications Vol. 2 0 9 867-876].
However, the crtO cDNA and its protein product exhibit substantial nucleic- and amino acid sequence identities with the nucleic- and amino acid sequence of a recently cloned cDNA encoding a 320 amino acids protein product having p-carotene oxygenase activity, isolated from Haematococcus pluvialis [see.
Kajiwara S, Kakizono T, Saito T, Kondo K, Ohtani T, Nishio N, Nagai S and Misawa N (1995) Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematoococcus pluvialis, and astaxanthin synthesis in Escherichia coli. Plant Molec Biol 29: 343-352]. Nevertheless, as presented in Figure 2 the degree of sequence identity between the crtO cDNA (CRTOA.SEQ in o1 Figure 2) and the cDNA described by Kajiwara et al. (CRTOJ.SEQ in Figure 2) [see reference above] is 75.7% and, as presented in Figure 3 the degree of sequence identity between the crtO cDNA protein product (CRTOA.AMI in Figure 3) and the protein described by Kajiwara et al. (CRTOJ.AMI in Figure 3) is 78%, as was determined using a GCG software.
As will be described in details hereinbelow, the crtO cDNA can thus be employed to biotechnologically produce (3S,3'S) astaxanthin in systems which are either easy to grow and can be used directly as an additive to fish food, or systems permitting a simple and low cost extraction procedure of astaxanthin.
In one embodiment, the present invention relates to a DNA segment coding for a polypeptide comprising an amino acid sequence corresponding to Haematococcus pluvialis crtO gene and allelic and species variations and functional naturally occurring and/or man-induced variants thereof. The phrase 'allelic and species variations and functional naturally occurring and/or maninduced variants' as used herein and in the claims below refer to the source of the 25 DNA (or RNA as described below) or means known in the art for obtaining it.
However the terms 'variation' and 'variants' indicate the presence of sequence dissimilarities variations). It is the intention herein and in the claims below that the sequence variations will be 77-80%, preferably 80-85%, more preferably 85-90%, most preferably 90-100% of identical nucleotides. In a preferred 30 embodiment the DNA segment comprises the sequence set forth in SEQ ID NO:1.
In another preferred embodiment, the DNA segment encodes the amino acid sequence set forth in SEQ ID NO:4.
The invention also includes a pure DNA segment characterized as including a sequence which hybridizes under high stringency conditions as described in Sambrook et al., Molecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1989] to a nucleic acid probe which includes at least fifteen, preferably at least fifty, more preferably at least hundred, even more preferably at least two hundred, even more preferably at least five 26 hundred successive nucleotides of SEQ ID NO:1 or SEQ ID NO:2. Alternatively.
the DNA segment of the invention may be characterized as being capable of hybridizing under low-stringent conditions to a nucleic acid probe which includes the coding sequence (nucleotides 166 through 1152) of SEQ ID NO:1 or SEQ ID NO:2. An example of such low-stringency conditions is as described in Sambrook et al.. using a lower hybridization temperature, such as, for example. 200C below the temperature employed for high-stringency hybridization conditions, as described above.
The DNA segment of the invention may also be characterized as being capable of hybridizing under high-stringent conditions to a nucleic acid probe which includes the coding sequence (nucleotides 166 through 1152) of SEQ ID NO:1 or SEQ ID NO:2.
The invention also includes a synthetically produced oligonucleotide oligodeoxyribonucleotide or oligoribonucleotide and analogs thereof) capable of hybridizing with at least ten-nucleotide segments of SEQ ID NO:I or SEQ ID NO:2.
In another embodiment, the present invention relates to an RNA segment coding for a polypeptide comprising an amino acid sequence corresponding to Haematococcus pluvialis crtO gene and allelic and species variations and functional naturally occurring and/or man-induced variants thereof. In a preferred embodiment the RNA segment comprises the sequence set forth in SEQ ID NO:2.
In another preferred embodiment, the RNA segment encodes the amino acid sequence set forth in SEQ ID NO:4.
The invention also includes a pure RNA characterized as including a 25 sequence which hybridizes under high stringent conditions to a nucleic acid probe which includes at least at least fifteen, preferably at least fifty, more preferably at least hundred, even more preferably at least two hundred, even more preferably at least five hundred succsesive nucleotides of SEQ ID NO:1 or SEQ ID NO:2.
Alternatively, the RNA of the invention may be characterized as being capable of 30 hybridizing under low-stringent conditions to a nucleic acid probe which includes the coding sequence (nucleotides 166 through 1152) of SEQ ID NO:1 or SEQ ID NO:2. Additionally, the RNA of the invention may be characterized as being capable of hybridizing under high-stringent conditions to a nucleic acid probe which includes the coding sequence (nucleotides 166 through 1152) of SEQ ID NO:1 or SEQ ID NO:2.
In another embodiment, the present invention relates to a polypeptide comprising an amino acid sequence corresponding to a Haematococcus pluvialis crtO gene and allelic, species variations and functional naturally occurring and/or 27 man-induced variants thereof. In a preferred embodiment, the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:4.
It should be noted that the invention includes any peptide which is homologous 80-85%, preferably 85-90%, more preferably 90-100% of identical amino acids) to the above described polypeptide. The term 'homologous' as used herein and in the claims below, refers to the sequence identity between two peptides. When a position in both of the two compared sequences is occupied by identical amino acid monomeric subunits, it is homologous at that position. The homology between two sequences is a function of the number of homologous io positions shared by the two sequences. For example, if eight often of the positions in two sequences are occupied by identical amino acids then the two sequences are homologous.
Other polypeptides which are also included in the present invention are allelic variations, other species homologs, natural mutants, induced mutants and is peptides encoded by DNA that hybridizes under high or low stringency conditions (see above) to the coding region (nucleotides 166 through 1152) of SEQ ID NO: 1 or SEQ ID NO:2.
In another embodiment, the present invention relates to a recombinant DNA molecule comprising a vector (for example plasmid or viral vector) and a DNA segment coding for a polypeptide, as described above. In a preferred embodiment, the DNA segment is present in the vector operably linked to a promoter.
In a further embodiment, the present invention relates to a host cell containing the above described recombinant DNA molecule or DNA segment.
Suitable host cells include prokaryotes (such as bacteria, including Escherichia "25 coli) and both lower eukaryotes (for example yeast) and higher eukaryotes (for example, algae, plant or animal cells). Introduction of the recombinant molecule into the cell can be effected using methods known in the art such as, but'not limited to, transfection, transformation, micro-injection, gene bombardment etc.
The cell thus made to contain the above described recombinant DNA molecules 9 30 may be grown to form colonies or may be made to differentiate to form a differentiated organism. The recombinant DNA molecule may be transiently contained by a process known in the art as transient transfection) in the cell.
nevertheless, it is preferred that the recombinant DNA molecule is stably contained by a process known in the art as stable transfection) in the cell. Yet in a preferred embodiment the cell is endogenously producing, or is made by genetic engineering means to produce, p-carotene, and the cell contains endogenous or genetically engineered p-carotene hydroxylase activity. Such a cell may be used as a food additive for animal salmon) arid human consumption. Furthermore.
such a cell may be used for extracting astaxanthin and/or other xanthophylls, as described hereinbelow.
In a further embodiment, the present invention relates to a host transgenic organism a higher plant or animal) containing the above described recombinant DNA molecule or the above described DNA segment in its cells.
Introduction of the recombinant molecule or the DNA segment into the host transgenic organism can be effected using methods known in the art. Yet, in a preferred embodiment the host organism is endogenously producing. or is made by genetic engineering means to produce, p-carotene and, also preferably the host io organism contains endogenous or genetically engineered p-carotene hydroxylase activity. Such an organism may be used as a food additive for animal salmon) and human consumption. Furthermore, such an organism may be used for extracting astaxanthin and/or other xanthophylls, as described hereinbelow.
In another embodiment, the present invention relates to a method of producing astaxanthin using the above described host cell or transgenic organism.
In yet another embodiment, the present invention relates to a method of producing xanthophylls such as canthaxanthin, echinenone, cryptoxanthin, isocryptoxanthin, hydroxyechinenone, zeaxanthin, adonirubin, 3-hydroxyechinenone, 3'hydroxyechinenone and/or adonixanthin using the above described host cell or transgenic organism. For these purposes provided is a cell or a transgenic organism as described above. The host cell or organism are made to grow under conditions favorable of producing astaxanthin and the above listed additional xanthophylls which are than extracted by methods known in the art.
In yet another embodiment, the present invention relates to a transgenic 25 plant expressing a transgene coding for a polypeptide including an amino acid sequence corresponding to Haematococcus pluvialis crtO gene, allelic and species variants or functional naturally occurring or man-induced variants thereof.
Preferably the expression is highest in chromoplasts-containing- tissues.
In yet another embodiment, the present invention relates to a recombinant 30 DNA vector which includes a first DNA segment encoding a polypeptide for S directing a protein into plant chloroplasts or chromoplasts derived from the Pds gene of tomato) and an in frame second DNA segment encoding a polypeptide including an amino acid sequence corresponding to Haematococcus pluvialis crtO gene, allelic and species variants or functional naturally occurring and maninduced variants thereof.
In yet another embodiment, the present invention relates to a recombinant DNA vector which includes a first DNA segment including a promoter highly expressible in plant chloroplasts or chromoplasts-containing tissues derived 29 from the Pds gene of tomato) and a second DNA segment encoding a polypeptide including an amino acid sequence corresponding to Haematococcus pluvialis crtO gene, allelic and species variants or functional naturally occurring and man induced variants thereof.
All references, including any patents or patent applications, cited in this specification are hereby incorporated by reference. No admission is made that any reference constitutes prior art. The discussion of the references states what their authors assert, and the applicants reserve the right to challenge the accuracy and pertinency of the cited documents. It will be clearly understood that, although a number of prior art publications are referred to herein, this reference does not constitute an admission that any of these documents forms part of the common general knowledge in the art, in Australia or in any other country.
For the purposes of this specification it will be clearly understood that the word "comprising" means 20 "including but not limited to", and that the word "comprises" has a corresponding meaning.
Reference is now made to the following examples, which together with the above descriptions, illustrate the invention.
EXAMPLES
The following protocols and experimental details are referenced in the Examples that follow: Algae and growth conditions. Haematococcus pluvialis (strain 34/7 from the Culture Collection of Algae and Protozoa, Windermere, UK) was kindly provided by Dr. Andrew Young from the Liverpool John Moores Universtiy. Suspension cultures of the alga were grown in a liquid medium as described by Nichols and Bold [see, Nichols HW, Bold HC (1964) Trichsarcina polymorpha gen et sp nov J Phycol 1: 34-39]. For induction of astaxanthin biosynthesis cells were harvested, washed in water and 29a resuspended in a nitrogen-depleted medium. The cultures were maintained in 250 ml Erlenmeyer flasks under continuous light (photon flux of 75 pE/m 2 at 25°C, on a rotary shaker at 80 rpm.
Construction of cDNA library. The construction of a cDNA library form Haematococcus pluvialis was described in detail by Lotan and Hirschberg (1995) FEBS letters 364: 125-128. Briefly, total RNA was extracted from algal cells grown for 5 days under nitrogen-depleted conditions (cell color brown-red). Cells from a 50 ml culture were harvested and their RNA content was extracted using Tri reagent (Molecular Research Center, INC.).
Poly-An RNA was isolated by two cycles of fractionation on oligo dT-cellulose (Boehringer). The final yield was of the total RNA. The cDNA library was constructed in a Uni-ZAP T XR vector, using a ZAP-cDNA synthesis kit (both fro Stratagene). Escherichia coli cells of strain XL1- Blue MRF' (Stratagene) were used for amplification of the cDNA library.
Plasmids and Escherichia coli strains. Plasmid pPL376, which contains the genes necessary for carotenoid biosynthesis int eh bacterium Erwinia herbicola was obtained from Tuveson [for further details regarding **plasmid pPL376 see, Tuveson RW, Larson RA Kagan J (1988) Role of cloned carotenoid genes expressed in Escherichia coli in protecting against inactivation by near-UV light and specific phototoxic molecules. J Bacteriol 170: 4675-4680]. Cells of Escherichia coli strain JM109 that carry the plasmid pPL376 accumulate the bright yellow carotenoid, zeaxanthin glycoside. In a first step, a 1.1 kb Sall-Sall fragment was deleted from this plasmid to inactivate the gene crtX, coding for zeaxanthin glucosyl transferase. In a second step, partial BamHI cleavage of the plasmid DNA, followed by self ligation, deleted a 0.8 kb fragment which inactivated crtZ, encoding P-carotene hydroxylase. A partial BglIl cleavage generated a fragment of 7.4 kb which was cloned in the BamHI site of the plasmid vector pACYC184. As shown in Figure 4, the resulting recombinant plasmid, which carried the genes crtE, crtB, crtI and crtY, was designated pBCAR [Lotan and Hirschberg (1995) FEBS letters 364: 125-128].
Plasmid pBCAR was transfected into SOLR strain cells of Escherichia coli (Stratagene). Colonies that appeared on chloramphenicol-containing Luria Broth (LB) medium [described in Sambrook et al., Molecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1989], carried this plasmid and developed a deep yellow-orange color due to the accumulation of 0-carotene.
As shown in Figure 5, an additional plasmid, designated pZEAX, which 2 allows for zeaxanthin synthesis and accumulation in Escherichia coli was 20 constructed [this plasmid is described in details in Lotan and Hirschberg (1995) FEBS letters 364: 125-128]. SOLR strain Escherichia coli cells were used as a host for the pZEAX plasmid. Escherichia coli cells were grown on LB medium (see above), at 37 0 C in the dark on a rotary shaker at 225 rpm. Ampicillin (50 p g/ml) and/or chloramphenicol (30 p.g/ml) (both from Sigma) were added to the S 25 medium for selection of appropriate transformed cells.
As shown in Figure 6, a plasmid, pHPK, containing the full length cDNA of the P-carotene C-4-oxygenase enzyme was identified by color complementation as described by Lotani and Hirschberg (1995) FEBS letters 364: 125-128 (see description herein below). A 1.2 kb PstI-PstI DNA fragment, containing the 30 cDNA of the P-C-4-oxygenase from Haematococcus pluvialis, was isolated from plasmid pHPK and inserted into a PstI site in the coding sequence of the crtZ gene in the plasmid pZEAX. This recombinant plasmid was designated pCANTHA and is shown in Figure 7.
The same 1.2 kb PstI-PstI fragment was also inserted into a PstI site whichexists 600 bp downstream of the crtE gene in the plasmid pZEAX. The resulting recombinant plasmid was designated pASTA and is shown in Figure 8.
The same 1.2 kb PstI-PstI fragment was also inserted into a PstI site which exists in the P-lactamase gene in the plasmid pPAN35D5 [Hirschberg J. Ohad N.
31 Pecker 1 and Rahat A (1987) Isolation and characterization of herbicide resistant mutants in the cyanobacterium Synechococcus R2. Z. Naturforsch 42c: 102-112], which carries the psbAl gene from the cyanobacterium Synechococcus PCC7942 in the plasmid vector pBR328 [Hirschberg J, Ohad N, Pecker I and Rahlt A (1987) Isolation and characterization of herbicide resistant mutants in the cyanobacterium Synechococcus R2. Z. Naturforsch 42c: 102-112]. This plasmid was designated and is shown in Figure 9. This plasmid was used in the transformation of Synechococcus PCC7942 cells following procedures described by Golden [Golden SS (1988) Mutagenesis of cyanobacteria by classical and gene-transfer-based methods. Methods Enzymol 167: 714-727].
Excision of pliage library and screening for a 1-carotene oxygenase gene. Mass excision of the cDNA library, which was prepared as described hereinabove, was carried out using the ExAssist helper phage (Stratagene) in cells of SOLR strain of Escherichia coli that carried the plasmid pBCAR. The excised library in phagemids form was transfected into Escherichia coli cells strain XL1- Blue and the cells were plated on LB plates containing 1 mM isopropylthio-p-Dgalactosidase (IPTG), 50 .tg/ml ampicillin and 30 p.g/ml chloramphenicol, in a density that yielded approximately 100-150 colonies per plate. The plates were incubated at 37 0 C overnight and further incubated for two more days at room 20 temperature. The plates were then kept at 4 0 C until screened for changes in colony colors.
A plasmid for high expression of crtO in chromoplasts. As shown in Figures 10-11, a genomic DNA sequence of a tomato species Lycopersicon esculentum (nucleotides 1 to 1448 of the Pds gene [as published in Mann V, Pecker I and Hirschberg J (1994) cloning and characterization of the gene for phytoene desaturase (Pds) from tomato (Lycopersicon esculentum). Plant Molecular Biology 24: 429-434], which contains the promoter of the Pds gene and the coding sequence for the amino terminus region of the polypeptide PDS that serve as a transit peptide for import into chloroplasts and chromoplasts, was cloned into a HindIII-Smal site of the binary plasmid vector pBIB, [described by Becker D (1990) Binary vectors which allow the exchange of plant selectable markers and reporter genes. Nucleic Acids Research 18:230], shown in Figure 10. The recombinant plasmid was designated pPTBIB and is shown in Figure 11.
As shown in Figure 12, a 1,110 nucleotide long Eco47III-Ncol fragment, containing the cDNA of crtO from H. pluvialis (nucleotides 211 to 1321 of SEQ ID NO:1) was sub-cloned into the Smal site of the plasmid pPTBIB (Figure 11) so that the coding nucleotide sequence of the amino terminus of 32 Pds is in the same reading frame as cr-1. The recombinant plasmid was designate pPTCRTOBIB.
Formation of transgenic higher plant. The DNA of pPTCRTOBIB was extracted from- E. coli cells and was transferred into cells of Agrobacterium tumefaciens strain EHA105 [described by Hood EE. Gelvin SB.
Melchers LS and Hoekema A (1993) Transgenic Research 2:208-218] using electroporation as described for E. coli [Dower JW, Miller FJ and Ragdsale WC (1988) High efficiency transformation of E. coli by high voltage electroporation. Nuc. Acids Res. 18: 6127-6145]. Agrobacterium cells were grown at 28 OC in LB medium supplemented with 50 Vtg/ml streptomycin and (tg/ml kanamycin as selective agents. Cells of Agrobacterium carrying pPTCRTOBIB were harvested from a suspension culture at the stationary phase of growth and used for transformation as described by Horsch RB. Fry JE, Hoffmann NL, Eicholtz D, Rogers SG and Fraley RT, A simple and general s1 method for transferring genes into plants. Science (1985) 227:1229-1231: and Jeffesrson AR, Kavanagh TA and Bevan WM (1987) GUS fusions: 3glucuronidase as a sensitive and versatile gene fusion marker in higher plants.
The EMBO J. 6: 3901-3907.
Leaf explants of Nicotiana tobaccum strain NN were infected with the 20 transformed Agrobacterium cells and kanamycin-resistant transgenic plants were regenerated according to protocols described by Horsch et al. (1985) and Jefferson et al. (1987) cited above.
With reference now to Figure 13, the presence of the DNA sequence of the crtO gene-construct in the fully developed regenerated plants was determined by 25 DNA Southern blot analysis. To this end DNA was extracted from the leaves [according to a protocol described by Kanazawa and Tsutsumi (1992) Extraction of restrictable DNA from plants of the genus Nelumbo. Plant Molecular Biology Reports 10: 316-318], digested with the endonuclease HindIII, the fragments were size separated by gel electrophoresis and hybridized with radioactively labeled 30 crtO sequence (SEQ ID NO: 1).
It was determined that each transgenic plant that was examined contained at least one copy of the crtO DNA sequence, yielding a 1.75 kb band (arrow).
originating from an internal HindIII-HindIII fragment of the T-DNA of pPTCRTOBIB, additional bands originating from partial digestion, additional band/s whose sizes vary, depending on the position of insertion in the plant genome and a 1.0 kb band originating from the tobacco plant itself which therefore also appears in the negative control WT lane.
Sequence analysis. DNA sequence analysis was carried out by the dideoxy method [see, Sanger F, Nicklen S Coulsen AR (1977) DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 74: 5463-5467].
Carotenoids analysis. Aliquots of Escherichia coli cells which were grown in liquid in LB medium were centrifuged at 13,000 g for 10 minutes, washed once in water and re-centrifuged. After removing the water the cells were resuspended in 70 jil of acetone and incubated at 65 0 C for 15 minutes. The samples were centrifuged again at 13,000 g for 10 minutes and the carotenoidcontaining supernatant was placed in a clean tube. The carotenoid extract was o0 blown to dryness under a stream of nitrogen (N 2 gas and stored at -20 0 C until required for analysis. Carotenoids from plant tissues were extracted by mixing 0.5-1.0 gr of tissue with 100 .l of acetone followed by incubation at 65 0 C for minutes and then treating the samples as described above.
High-performance liquid chromatography (HPLC) of the carotenoid extracts was carried out using an acidified reverse-phase C18 column, Spherisorb ODS-2 (silica 5 utm 4.6 mm x 250 mm) (Phenomenex®). The mobile phase was pumped by triphasic Merck-Hitachi L-6200A high pressure pumps at a flow rate of 1.5 ml/min. The mobile phase consisted of an isocratic solvent system comprised rof hexane/dichloromethane/isopropyl alcohol/triethylamine (88.5:10:1.5:0.1, v/v).
20 Peaks were detected at 470 nm using a Waters 996 photodiode-array detector.
Individual carotenoids were identified by their retention times and their typical absorption spectra, as compared to standard samples of chemically pure [3carotene, zeaxanthin, echinenone, canthaxanthin, adonirubin and astaxanthin (The latter four were kindly provided by Dr. Andrew Young from Liverpool John 25 -Moores University).
Thin layer chromatography (TLC) was carried out using silica gel 60 F254 plates (Merck), using ethyl acetate/benzene v/v) as an eluent. Visible absorption spectra were recorded with a Shimadzu UV-160A spectrophotometer.
All spectra were recorded in acetone. Spectral fine structure was expressed in 30 terms of %III/II [Britton, G. (1995). UV/Visible Spectroscopy. In: Carotenoids; Vol IB, Spectroscopy. Eds. Britton G, Liaaen-Jensen S and Pfander H.
Birkhauser Verlag, Basel. pp. 13-62].
Isolation and identification of the carotenoids extracted from cells of E. coli are treated in order of increasing adsorption (decreasing Rfvalues) on silica TLC plates. Carotenoids structure and the biosynthesis pathway of astaxanthin are given in Figure 14. The following details refer to the carotenoids numbered 1 through 9 in Figure 14.
p-Carotene R0fO.92 inseparable from authentic R .VIS Xmax nm: (428), 452, 457, %III/II 0.
Echinenone R0fO.90 inseparable from.authentic Rt .VIS ?nmnax nm: 455. %III/II 0.
Canthaxanthin Rf0.87. inseparable from authentic Rt .VIS 2nmax nm: 470. %III/II 0.
-Cryptoxanthin Rf0.83. Rt .VIS Xnax nm: (428), 451, 479. %111/1I 0.
Adonirubin Rf0.82 inseparable from authentic Rt .VIS mnax nm: io 476. %II/II 0.
Astaxanthin Rf 0.79 inseparable from authentic R, .VIS ?max nm: 477, %III/II 0.
Adonixanthin Rf0.72. Rt .VIS Xmax nm: 464, %III/II 0.
Zeaxanthin Rf0.65 inseparable from authentic R, .VIS AXmax nm: (428). 451, 483, %III/II 27.
Hydroxyechinenone RfO.80, Rt, 3.0. VIS tmnax nm: 464, %III/II 0.
Chirality configuration. Chirality configuration of astaxanthin was determined by HPLC of the derived diastereoisomeric camphanates of the astaxanthin [Renstrom B, Borch G, Skulberg M and Liaaen-Jensen S (1981) Optical purity of (3S,3S)-astaxanthin from Haematococcus pluvialis. Phytochem 2561-2565]. The analysis proved that the Escherichia coli cells synthesize pure (3S,3'S) astaxanthin.
~EXAMPLE 1 S 25 Cloning the -C-4-oxygenase gene A cDNA library was constructed in Lambda ZAP II vector from poly-An RNA of Haematococcus pluvialis cells that had been induced to synthesize astaxanthin by nitrogen deprivation as described hereinabove. The entire library 30 was excised into P-carotene-accumulating cells of Escherichia coli, strain SOLR.
which carried plasmid pBCAR (shown in Figure Screening for a P-carotene oxygenase gene was based on color visualization of colonies of size of 3 mm in diameter. Astaxanthin and other oxygenated forms of P-carotene xanthophylls) have distinct darker colors and thus can be detected from the yellow -carotene background. The screening included approximately 100.000 colonies which were grown on LB medium plates containing ampicillin and chloramphenicol that selected for both the Lambda ZAP II vector in its plasmid propagating form and the pBCAR plasmid. Several colonies showed different color tones but only one exhibited a conspicuous brown-red pigment. This colony presumed to contain a xanthophyll biosynthesis gene was selected for further analysis described hereinbelow in the following Examples.
EXAMPLE 2 Analysis of the P-C-4-oxygenase activity in Escherichia coli The red-brown colony presumed to contain a xanthophyll biosynthesis gene (see Example 1 above) was streaked and further analyzed. First, the recombinant ZAP II plasmid carrying the cDNA clone that was responsible for xanthophyll synthesis in Escherichia coli was isolated by preparing plasmid DNA from the redbrown colony, transfecting it to Escherichia coli cells of the strain XL 1-Blue and selection on ampicillin-containing medium. This plasmid, designated pHPK (pHPK is a Lambda ZAP II vector containing an insert isolated from the red-brown 1i colony), was used to transform P-carotene-producing Escherichia coli cells (Escherichia coli SOLR strain that carry the plasmid pBCAR shown in Figure 4) resulting in the formation of red-brown colonies. Carotenoids from this transformant, as well as from the host cells (as control) were extracted by acetone and analyzed by HPLC.
20 HPLC analysis of carotenoids of the host bacteria which synthesized P- .carotene (Escherichia coli SOLR strain that carry the plasmid pBCAR shown in Figure as compared with a brown-red colony, revealed that only traces of Pcarotene were observed in the transformant cells while a new major peak of canthaxanthin and another minor peak of echinenone appeared [described in detail 25 by Lotan and Hirschberg (1995) FEBS letters 364: 125-128]. These results indicate that the cDNA in plasmid pHPK, designated crtO encodes an enzyme with t-C-4-oxygenase activity, which converts P-carotene to canthaxanthin via echinenone (see Figure 14). It is, therefore concluded that a single enzyme catalyzes this two-step ketonization conversion by acting symmetrically on the 4 and 4' carbons of the P- and p'-rings of p-carotene, respectively.
EXAMPLE 3 Production of astaxanthin in Escherichia coli cells To determine whether P-carotene hydroxylase a product of the crtZ gene of Erwinia herbicola) can convert thus produced canthaxanthin to astaxanthin and/or whether zeaxanthin converted from p-carotene by p-carotene hydroxylase can be converted by p-C-4-oxygenase to astaxanthin, the crtO cDNA of Haematococcus pluvialis thus isolated, was expressed in Escherichia coli cells together with the crtZ gene of Erwinia herbicola. For this purpose, Escherichia coli cells of strain SOLR were transfected with either plasmid pASTA alone containing, as shown in Figure 8, both crtZ and crtO or, alternatively with both plasmids, pHPK containing, as shown in Figure 6, crtO, and pZEAX containing, as shown in Figure 5, crtZ. Carotenoids in the resulting transformed cells were extracted and analyzed by HPLC as described above. The results, given in Table 1, show the composition of carotenoids extracted from the cells containing the plasmid pASTA. Similar carotenoid composition is found in Escherichia coli cells io which carry both pHPK and pZEAX.
TABLE I Carotenoid of total carotenoid composition P-Carotene Echineone 1.7 P-Cryptoxanthin 4.2 Canthaxanthin 4.2 Zeaxanthin 57.8 SAdonirubin Adonixanthin 17.9 Astaxanthin 5.2 The results presented in Table 1, prove that carotenoids possessing either a 3-end group or a 4-keto--end group act as substrates for the hydroxylation reactions catalyzed by crtZ gene product at carbons C-3 and The hydroxylation of p-carotene and canthaxanthin results in the production of zeaxanthin and astaxanthin, respectively. These hydroxylations result in the production of astaxanthin and the intermediate ketocarotenoids, 3hydroxyechinenone, adonixanthin and adonirubin. These results further demonstrate that astaxanthin can be produced in heterologous cells by expressing the gene crtO together with a gene that codes for a 0-carotene hydroxylase.
EXAMPLE 4 Sequence analysis of the gene for P-carotene C-4-oxygenase The full length, as was determined by the presence of a poly A tail, of the cDNA insert in plasmid pHPK (1771 base pairs) was subjected to nucleotide 37 sequence analysis. This sequence, set forth in SEQ ID NO:1, and its translation to an amino acid sequence set forth in SEQ ID NO:3 (329 amino acids), were deposited in EMBL database on May 1, 1995, and obtained the EMBL accession numbers X86782 and X86783, respectively.
An open reading frame (ORF) of 825 nucleotides (nucleotides 166 through 1152 in SEQ ID NO:3) was identified in this sequence. This ORF codes for the enzyme P-carotene C-4-oxygenase having 329 amino acids set forth in SEQ ID NO:4. as proven by its functional expression in Escherichia coli cells (see Example 3 above). The gene for this enzyme was designated crtO.
EXAMPLE Transformation of cyanobacteria with crtO The plasmid DNA of pPAN3.5-KETO, shown in Figure 9, was transfected into cells of the cyanobacterium Synechococcus PCC7942 according to the method described by Golden [Golden SS (1988) Mutagenesis of cyanobacteria by classical and gene-transfer-based methods. Methods Enzymol 167: 714-727]. The cyanobacterial cells were plated on BG11 medium-containing petri dishes that contained also chloramphenicol. Colonies of chloramphenicol-resistant 20 Synechococcus PCC7942 which appeared after ten days were analyzed for their carotenoid content. As detailed in Table 2 below, HPLC analysis of these cells revealed that the major carotenoid components of the cells was p-carotene, echinenone; canthaxanthin, adonirubin and astaxanthin. A similar analysis of the wild type strain and of Synechococcus PCC7942 transfected with a plasmid in which the orientation of the crtO gene is reversed (not shown), which is therefore not capable of producing an active protein, did not revealed production of echinenone, canthaxanthin, adonirubin and astaxanthin.
These result prove that crtO of Haematococcus pluvialis can be expressed in cyanobacteria and that its expression provided a p-C-4-oxygenase enzymatic activity needed for the conversion of P-carotene to canthaxanthin. This result further demonstrates that the endogenous P-carotene hydroxylase of Synechococcus PCC7942 is able to convert thus produced canthaxanthin to astaxanthin. Since the carotenoid biosynthesis pathway is similar in all green photosynthetic organism [see Figures 1 and 10 and, Pecker I, Chamovitz D. Linden H, Sandmann G and Hirschberg J (1992) A single polypeptide catalyzing the conversion of phytoene to (-carotene is transcriptionally regulated during tomato fruit ripening. Proc Natl Acad Sci USA 89: 4962-4966] it is deduced that astaxanthin can be produced in algae, and higher plants by expressing crtO in any 38 tissue that express also the endogenous P-carotene hydroxylase. It is further deduced that astaxanthin can be produced by any organism provided it contains either endogenous or engineered P-carotene biosynthesis pathway, by expressing crtO in any tissue that express either endogenous or genetically engineered Pcarotene hydroxylase.
TABLE 2 Carotenoid of total carotenoid composition P-Carotene 31.5 Echinenone 18.5 Canthaxanthin 16.1 Zeaxanthin 22.3 Adonirubin Astaxanthin 5.6 EXAMPLE 6 Deterinming the chirality configuration of astaxanthin produced in heterologous systems The chirality configurations of astaxanthin produced by Escherichia coli S. cells, as described under Example 3 hereinabove, and by cyanobacterium Synechococcus PCC7942 cells, as described in Example 5 hereinabove, were determined by HPLC of the derived diastereoisomeric camphanates of the astaxanthin [Renstrom B, Borch G, Skulberg M and Liaaen-Jensen S (1981) Optical purity of (3S,3S')-astaxanthin from Haematococcus pluvialis. Phytochem 2561-2565]. The analysis proved that the Escherichia coli and Synechococcus PCC7942 cells described above, synthesize pure (3S,3'S) astaxanthin.
EXAMPLE 7 Transformation of a higher plant with crtO Producing natural astaxanthin in higher plants has two anticipated benefits. First, as a pure chemical, astaxanthin is widely used as feed additive for fish. It is a potential food colorant suitable for humans consumption and has potential applications in the cosmetic industry. Second, inducing astaxanthin biosynthesis in vivo in flowers and fruits will provide attractive pink/red colors which will increase their appearance and/or nutritious worth.
39 In flowers and fruits carotenoids are normally synthesized and accumulated to high concentration in chromoplasts, a typical pigmentcontaining plastids, thus providing typical intense colors to these organs.
Inducing synthesis of astaxanthih in chromoplasts enables the accumulation of high concentration of this ketocarotenoid. Over-expression of carotenoid biosynthesis genes which results in elevated concentrations of carotenoids in chloroplasts, or other alterations in carotenoid composition in chloroplasts may damage the thylakoid membranes, impair photosynthesis and thus is deleterious to-the plants. In contrast, increase of carotenoid concentration or alteration in 1o carotenoid composition in chromoplasts do not affect the viability of the plant nor the yield of fruits and flowers.
Thus, gene-transfer technology was used to implant the crtO gene isolated from the alga Haematococcus pluvialis, as described, into a higher plant, in such a way that its expression is up-regulated especially in chromoplast-containing cells.
To this end, a T-DNA containing binary plasmid vector as shown in Figure 12 was assembled in E. coli from the promoter and coding DNA sequences of the transit peptide encoded by the Pds gene from a tomato species Lycbpersicon esculentum, linked to the coding DNA sequence of crtO from H 20 pluvialis. Upon stable transfer of this DNA construct via Agrobacteriummediated transformation into a tobacco (Nicotiana tabacum NN) plant to form a transgenic plant, as described under methods above, the plant acquired the ability to produce ketocarotenoids especially in flower tissues (chromoplastcontaining cells). It should be noted that the Pds gene promoter is capable of directing transcription and therefore expression especially in chloroplasts and/or chromoplasts-containing tissues of plants. It should be further noted that the transit peptide encoded by part of the Pds coding sequence is capable of directing conjugated in frame) proteins into plant chromoplasts and/or chloroplasts.
As shown in Figure 15, in chromoplasts-containing cells, such as in the nectary tissue of the flower of tobacco, this DNA construct induces accumulation of astaxanthin and other ketocarotenoids to:a higher level which alters the color from the normal yellow to red.
Concentration and composition of carotenoids in chloroplasts-containing tissues, such as leaves, and in chromoplast-containing tissues, such as flowers, were determined in the transgenic plants and compared to normal nontransformed plants.
Carotenoids compositions in leaves (chloroplasts-containing tissue) and in the nectary tissue of flowers (chromoplast containing tissue) of wild type and transgenic tobacco plants were determined by thin layer chromatography
(TLC)
and by high pressure liquid chromatography (HPLC) as described above.
Total carotenoids concentration in leaves (chloroplasts-containing tissue) and in the nectary tissue of flowers (chromoplast containing tissue) of wild type and transgenic tobacco plants are summarized in Tables 3 below.
Percents of carotenoids composition in leaves of wild-type and transgenic tobacco plants are summarized in Tables 4 below.
Percents of carotenoids composition in the nectary tissue of flowers of wild-type and transgenic tobacco plants are summarized in Tables 5 below.
TABLE 3 (tg carotenoids per gr fresh weight Wild-type Transgenic with crtO Leaf (Chloroplasts) 200 240 Nectary tissue (Chromoplasts) 280 360 TABLE 4 of total carotenoids composition in chloroplasts-containing tissue (leaf) Wild-type Transgenic P-carotene 29.9 26.7 neoxanthin 5.0 5.9 violaxanthin -11.6 18.1 antheraxanthin 4.9 2.6 lutein 43.9 41.4 zeaxanthin 4.7 4.3 astaxanthin adonirubin 0.0 41 TABLE of total carotenoid composition in chromoplasts-containing tissue (flower) Wild-type Transgenic beta-carotene 58.1 21.0 violaxanthin 40.3 lutein 0.0 1.1 zeaxanthin 1.6 hydroxyechinenone 0.0 13.7 3'hydroxyechinenone 0.0 4.1 adonirubin 0.0 22.4 adonixanthin 0.0 8.7 astaxanthin 0.0 26.5 Please note the elevated content of hydroxyechinenone.
3'hydroxyechinenone, adonirubin, adonixanthin and astaxanthin especially in the chromoplast containing tissue of the transgenic tobacco plants.
20 Thus, the present invention successfully addresses the shortcomings of the presently known configurations by enabling a relatively low cost biotechnological production of (3S,3'S) astaxanthin by providing a peptide having a P-C-4oxygenase activity; a DNA segment coding for this peptide; an RNA segments coding for this peptide; a recombinant DNA molecule comprising a vector and the DNA segment; a host containing the above described recombinant DNA molecule or DNA segment; and of a method for biotechnologically producing (3S,3'S) astaxanthin or a food additive containing (3S.3'S) astaxanthin, using the host.
While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications and other applications of the invention may be made.
The entire disclosure in the complete specification of our Australian Patent Application No. 47436/97 is by this cross-reference incorporated into the present specification.
GENERAL INFORMATION:
APPLICANTS:
(ii) TITLE OF INVENTION: (iii) NUMBER OF SEQUENCES: (iv) CORRESPONDENCE ADDRESS:
ADDRESSEE:
STREET:
CITY:
STATE:
COUNTRY:
ZIP:
COMPUTER READABLE FORM: MEDIUM TYPE:
COMPUTER:
OPERATING SYSTEM: SEQUENCE LISTING Joseph Hirschberg, Tamar Lotan and Mark Harker Polynucleotide molecute from Haematococcus pluvialis encoding a polypeptide having a P-C-4-oxygenase activity for biotechnoLogical production of (3S,3'S) astaxanthin.
4 Mark M. Friedman c/o Robert Sheinbein 2940 Birchtree space Lane Silver Spring Marylan Jnited 20906 C C
C
SOFTWARE:
(vi) CURRENT APPLICATION DATA: APPLICATION NUMBER: FILING DATE:
CLASSIFICATION:
(vii) PRIOR APPLICATION DATA: APPLICATION NUMBER: FILING DATE: (viii) ATTORNEY/AGENT INFORMATION:
NAME:
REGISTRATION NUMBER: REFERENCE/DOCKET NUMBER: (ix) TELECOMMUNICATION INFORMATION:
TELEPHONE:
TELEFAX:
TELEX:
INFORMATION FOR SEQ ID NO:1: SEQUENCE CHARACTERISTICS: d States of America 1.44 megabyte, 3.5" microdisk Twinhead Slimnote-890TX MS DOS version 6.2, Windows version 3.11 Word for Windows version Friedmam, Mark M.
33,883 325/5 972-3-5625553 972-3-5625554
LENGTH:
be..
TYPE:
STRANDEDNESS:
TOPOLOGY:
(xi) SEQUENCE DESCRIPTION: GGC ACG AGC TTG CAC GCA AGT CAG CGC GI TCC ACA GCC TCA AAT AAT AAA GAG CTC A, TGG CCA GTC TGC ACT.GCC TTG AAC CCG Ci TGC CAT AGC ACA GCT AGA CGA ATG CAG C GAG CAG CTT ACC GGA AGC GCT GAG GCA C GTT GCA GGC AGC TCT GAC GTG TTG CGT A, CTT CCG TCA GAA GAG TCA GAC GCG GCC C, TAC AAG CCA CCA CCT TCC GAC ACA AAG G, CTC ATC GGC TCC TGG GCC GCA GTG TTC C AAG CTT CCG ACC TCC TTG GAC CAG CTG C, GCC ACA GCT CAG CTC GTT AGC GGC ACG Al 1771 base pairs nucleic acid double linear SEQ 10 NO:1: CAA GTC AAC ACC TGC CGT TTG TGC CCC TCG GTC TCC CGC CGC ACT GCA GCG ACA GTA ATG AAG GAG AAG GAG AAG TGG GCG ACC CAG TAC CCG*GGA CTG AAG AAT ATC ACA ATG GCG CTA CAC GCC ATT TTT CAA TGG CTG CCC GTG TCA AGC CTG CTC GAC ATC CIA GTA TIC TT ACG CAT GAT GCT AAT GAC TTC TTC TAC AAC ATG CTG GAG GIG CCC AAG CCC TGC TTT GCC GCG CGC CTC CCA ATG GC AAC CTC TIC CGC rrc TTC GGC CCC GCG TCA CGC ACT AGC CAG ITC GAC CTG CAC GAG CTG CCC AAC TAG CTG GAC ACA TGT GCC AGG ACT ACG CIC CAT CCC TTG TAG CTG TCG CCA CTA CAC CCA GAG GAG TGT TGG CCC TTT AGG GGA GIG CAC GCA CAA AGA CCI GC CCA AAT CCT CCC GGT AlT CIT TCA CCA AGG TCA GGA GAG ICC GC TAT CAA CIC CTG ATG CAT CCC AGA CAC CC GAC CCI ACC TTC TGC ICC CTG GIG TAC TTT CCC TCT CC TCC TCC GAG TGC CC CTG CAC CCC TGA CTA CCC AGC TIC CA GCC GCA GTG CC ACA CCT AGC CCC ICC GIG CCA GIC ICA TGA CTA GC GTA GAG TTC CTC TAC CCC ACC ATC GCC CIA TCC ATC ICC AAC CAT ICC GAG GAC TIC CAC AG AIC ICC ACC TAC ACG GIG GTC ATG TTC ATC CC GCC CCC ACG TAC ATC TCA CCA CCC GIC CAC CTG GTC AC CAC CAC CCC TGC CCC CTC TCT GC TGC CCC CIG CTC GCT GAA AAG CTC ICT CIA CI CC CCC CAT GCA TCA AAC ACC CIT CCA TAG ATG CTA TGA CTT ACT 6CT CCC CTGCGAC GAG CAC TCC CAC ACC CAC GTG'AGA CC GC CTT All CTI TGA TCA ACA ACT ICA ACA AlA AAG T&C ACA GCC AIC AGA TIC TAC CAC CAC CCA AAC AIC TCG CAC CIG CC CCC CCC CAC ATC AAC III CTC CCC TTC CCA GGT CCA CI CAC CC CCC ACT AGC IT CCA CAT TIC TAT CAC GCA ICC GIG ICC CCA TCA TTA TAT AGA GAG CTG
TC
CTT TTT AIC AAC AGC CAG CCC ICC TII AAC CAC ACT CCI CCC ATI ATC ICC CAC CTG CCI CC ATC CIC TCC AAG CCI GAG TGC ICC AAC ACC ICC TAC CCC CCC TCC CIC CIT CCI CCC CAT GCA CTG CTC CCC ACC CCA CCC CTA GIG CTG CTC TIC CCI CTT AAT CI ACC CCC IC CCA CCC ACC AGA CCA GC ACT CCC CIA TAC ICC TCA GIG CCC GC 576 624 672 720 768 816 864 912 960 100.8 1056 1 104 1152 1200 1248 1296 1344 1392 1440 1488 1536 1584 1632 1680 1728 1771 9* 9 9 9**9 9*99 99 .9 .9*t .99* 99 9 9 *99999 9999 9 9*99 9 INFORMATION FOR SEC ID NO:2: 0I) SEQUENCE CHARACTERISTICS: LENGTH: 1771 bases TYPE: nucleic acid SIRANDEDNESS: single TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEC ID NO:2: ACC UUG CCC UCA CUC UGC ACC ACA CUU ACC CCC AC UCA GAA CCA CCA CCC UCC CCC ACC CCU CAC UUC UUU GAU CCU UUC UUC AUG CUC CCC AAG UUU CC CUC CCA AAC CUG UUG UUC CC UCA ACC CAG CCA ACU CAG CCC CC AAU AAA GAG CUC AAC GCC UUG MAC CCC CCA AGA CCA AUG CAC CUA AGC GCU GAG GCA CUC GAC GUG UUC CCU ACA UCA CAC CC CCC CC UCC CAC ACA MCG GCC GCC GCA CUC UUC CUC UUG GAC CAC CUC CAC GUU ACC CCC ACG AGC CUC GAG UUC CUG UAC CAU GC:ACC AUC GCC AGA CUA UGC AUC UCC CGC AAC CAU UCG GAG CCU CAC UUC CAC ACC UUC AUG UCC ACC UAC UCC ACG GUG GUC AUG GUG UUC AUG CC GCC UUU CCC ACG UAC AUG UCU UCA CCA CCC CUC CAA CUC AAC ACC UGC CCC CCU UUG UGC CCC UCC ACC CUC UCC CCC CCC ACU GAC OCA CC ACA CUA AUG UUC AAG GAG AAC GAG MCG GAG UGG GC ACC CAC UAC UCC CCC GCA CUG MCG MU CC AUC ACA AUG CC CUA CCU CAC GCC AUU UUUI CAA AUC UCG CUG CCC CUG UCA GAU ACC CUCG CUC GAC AUC CUC ACA CCC CUU UUU AUC ACC AUG AGA AAC AGG CAC CUU UUC UAC CCC UGG UUU GAU CAC CAC AAC CAC ACU GC GCA AAC CCU CCC AUU GUC AUG UCC AUG UCC CAC UUU CAC CUC CUC CCU CC CCA GCG CCC AUC CUG UCC GCC CCC CAC AAC CCU GAG CCU AUG AAC UCG UCG MCG UCG UUU CUC ACC UGC UAC CAC C UCC GAC CUG CUC AC UUC GAC CUCG CAC UGG GAG CAC CAC CCC UGC CCC UJUC GCC CCC UGG UIGG GAG CUG CCC AAC UGC CGC CCC CUC UCU UAG CUG GAC ACA CUC CAC UCG CCC CUG UGU CCC AGG ACU ACG CUG CAU GGG UUG UAC CUIG UCG GGA CUA CAC CCA GAG GAG UGU UGC GCC UUU AGG CCA CUG CAC CCA CAA- AGA GCU CC CGA AAU GCU CCC GGU CCC UCA CCU CUA CCC UCU AGC UUC CCC CAC CCC AAC GCA CUC UAG CC ACA CUU CCU ACC CUC CCC UCC UC CUC CCA CUC CCC CGA CCU CUCG CUC CCA CCU CCC CUCG CAC CC CUC CCC CCC ACU AGG UCA ACC UCU CUA CCA CCA CAU CUC UCA UUG UAU CUU CCC CAC CCA ACC CAC UCC CUG CCA CUU CCU GCC CAU CCA CGU CUG CCC GAC CCA CCC CCU CUC CUC CAC UUC CCU CCC AAU CCU CAA CCC UCC AAC CCC ACC UCA CCA UCC UC 1104 1152 1200 1248 1296 1344 1392 1440 1488 1536 1584 1632 1680 1728 1771 CAC ACC CAC UCC CCA AGA AUU CUU UCA CCA CUC UCA CU AGA CCU CC UGA UUA ACU CCC CUA UG AUU CUU UGA UAU AGA UAC UGG UCA GC ACG UCA CCA CAC UGA CUA UCGA ACA AGU UCA GAG UGC GCU UAU CAA GCU CUA ACA AUA AAC UCC UUC GUG GUC CCC UGC CCC INFORMATION FOR SEQ I0 NO:3: SEQUENCE CHARACTERISTICS: LENGTH: 1771 base pairs TYPE: nucteic acid STRANDEDNESS: double TOPOLOGY: linear (xi) 'SEQUENCE DESCRIPTION: SEQ ID NO:3: 9@S* 0
S
S
*5 S S
S*
0 *0 0 0 *500 *0*g CCC ACG AGC TTG CAC TCC ACA CCC TCA AAT TCC CCA GTC TCC ACT TGC CAT AGC ACA CCT CCA ACT CAC CCC CC CAA CTC AAC ACC TCC CCC AAT AAA GAG CTC AAG CGT TTG TGC CCC TCG ACG CC TTC AAC CCC CCA GTC TCC CCC CCC ACT CAC AGA CGA ATG CAG CTA GCA C ACA GTA ATG TTG Met Gin Leu Ala Ala Thr VaL Met Leu GAG CAG CTT Gtu Gin Leu ACC GGA ACC GCT Thr Gly Ser Ala GAG CCA CTC AAC Clu Ala Leu Lys GAG AAG GAG AAG Clu Lys Ctu Lys
GTT
Vat GCA CCC ACC TCT CAC GTC TTC CCT ACA TGC CC ACC CAG ALa Gty Ser Ser Asp Vat Leu Arg Thr Trp Ala Thr Gin CTT CCC TCA Leu Pro Ser TAC AAG CCA Tyr Lys Pro 60 GTC ATC GC Vat lie Gty 75 30 GAA GAG TCA GAC CC CCC CCC CCC GGA CTG Clu Giu Ser Asp Ala Ala Arg Pro GLy Leu 50 CCA CCT TCC CAC ACA AAG CCC ATC ACA ATG Pro Pro Ser Asp Thr Lys Gly Ile Thr Met 65 TCC TGG CCC GCA GTC TTC CTC CAC CCC ATT Ser Trp Ala Ala Vat Phe Leu His Ala Ile 80 Ar.
AAG AAT CC Lys Asn Ala CC CTA CGT Ala Leu Arg TTT CAA ATC Phe Gin Ile CTT CCC ACC TCC TTC GAC CAC CTG CAC Leu Pro Thr Ser Leu Asp Gin Leu His CTG CCC CTC TCA Leu Pro Vat Ser CCC ACA CCT CAG CTG Ala Thr Ala Gin Leu 110 CTA GTA TTC TTT GTC VaL Vat Phe Phe Vat 125 ACG CAT CAT GCT ATG Thr His Asp Ala Met 140 CTT ACC CCC ACC VaL Ser Gly Thr CTG GAG TTC C.TG Leu Ciu Phe Leu 130 AGC CTC CTC CAC Ser Leu Leu Asp ATC CTC Ilie Vat 120 TAC ACA CCC CTT Tyr Thr Gly Leu TTT ATC ACC Phe Ile Thr 135 ACG CAG CTT Arg Gin Leu CCC ACC ATC CC GLy Thr Ilie Ala 145 ATC AGA Met Arg AAT GAC TTC HTG GGC AGA GTA TGC ATC TCC TTG TAC GCC TCC nTT GAT Asn Asp Phe Leu GLY Arg Vat Cys lie Ser Leut Tyr Ala Trp Phe Asp 155 160 165 TAC AAC ATG CTG CAC CCC AAG CAT TGG GAG CAC CAC AAC CAC ACT GGC Tyr Asn Met 170 GAG GTG GC Gtu Vat Cly Leu His Arg Lys His Trp Giu His His Asn His Thr Gly 175 180 185 AAG GAC CCT GAC TTC CAC AGO GCA AAC CCT CCC ATT GTG Pro Asp Phe CCC TGG TTT CCC ACC TTC Pro Trp, Phe Ala Ser Phe 205 CC CCC CTC GCA TCC TG Ala Arg Lett Ala Trp Trp 220 ATG GC AAC CTC CTG GTG Met ALa Asn Leu Leut Vat 235 TTC CCC TTG TTC TAC TTT Phe Arg Lett Phe Tyr Phe ATG TCC Met Ser ACG GTC Thr Vat 225 TTC ATG Phe Met His Arg Gty Asn Pro Gty Ilie Vat 195 200 AGC TAC ATG TCG ATC TGG CAG TTT Ser Tyr Met Sec Met Trp Gin Phe 210 215 CTC ATO CAC CTG CTG COT CC CCA Vat Met Gin Leu Lett GLy Ala Pro 230 CC CCC CC CCC ATC CTG TCC CC Ala Ala Ala Pro Ilie Leu Ser Ala 240 CCC ACG TAC ATG Gty Thr Tyr Met.
245 CAC AAC CCT GAG His Lys Pro GLu CCGC CCC CC TCA Gly Ala Ala Sec CCC ACT ACC CAC Acg Thr Sec Gin 285 Go 0 40 0 0000 *.00 0@ 00*00 :00* 00 0 0000 00000 CCC TCT TCA CCA CCC GTC ATG AAC TGG Cly Sec Sec Pro Ala Vat Met Asn Trp 270 275 GC TCC GAC CTG GTC ACC TTT CTG ACC Ala Sec Asp Leu Vat Sec Phe Lett Thc 290 TGG GAG CAC CAC CCC TGC CCC TTC GCC Tcp, Gtu His His Arg Trp Pro Phe Ala 305 310 TGC CCC CCC CTG TCT GGC CGA CCT CTG Cys Arg Acg Leu Sec Cly Arg Cly Lett TGG AAC TCG Trp Lys Sec 280 TCC TAC CAC Cys Tyr His 295 CCC TGO TGC Pro Trp Trp CTT CCT CC Vat Pro Ala 672 720 768 816 864 912 960 1008 1056 1104 1152 1200 1248 1296 1344 1392 1440 1488 1536 1584 1632 1680 1728 1771 TTC CAC Phe Asp CTC CAC Lett His 300 GAG CTC CCC AAC Glu Lett Pro Asn 315 TAG CTC GAC ACA TGT CCC AGG ACT ACC CTG CAT CCC TTG TAG*CTC TCG CTG CAG CCC TCA CTA CCC AGC TTC 320 TCG CCC CTC CCT GAA AAC TCT CTA CCT CCC CAT CGA AAC ACC CTT TAG ATG CTA 325 CTG CCA GCT CCC CTC CAC CC CTG CCC CCC ACT AG TGA AGC TCT CTA GCA CGA CAT CTC TCA TTG TAT CTT GCA GTA GAG GAG CCC TTT CTC CAG AGA CCT AAT CCT ATT CTT AGC TCA TGC GCT CAC CCA CAC GCC TCT TGC GCA GTC AGO CCA GC ACA CTT ACT CCT CCC CAC GCA GCA CAA CCT ACG CTG GAC GAG GAC TCC CTG CC GGA CCC TGG TCC CAC ACC CAC TOG CCA GCC CGT GTG GCA GTG ACA GCT CC TGA TTA TGA GCA GTC TCA CTT ATT CTT TGA TAT AGA GCA GAG TGA CTA TCA ACA ACT TGA GAG CTG TAT GAA OCT GTA ACA ATA AAC TGG TTC
ACG
GCA
AGA
ACT
TAC
CTG
INFORMATION FOR SEQ ID NO:4': SEQUENCE CHARACTERISTICS: LENGTH: 329 amino acids TYPE: amino acid TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Met Gin Leu Ala Ala Thc Vat Met Leut Ciu Gin Leu Thr Cly Sec Ala Glu Ala Lett Lys Glu Lys Clu Lys GLu Val Ala Leu Pro Tyr Lys Val Ilie Gly Ser Set Gtu Pro Pro Gty Ser Set Asp Vat Leu Atg Gtu Set Asp Ala Ala 50 Pro Set Asp Tht Lys 65 Trp Ala ALa Vat Phe 46 fTp Ala Thr Gin Tyr Set Pro GtY Leu Lys Asn Ala lie Tht Met Ala Leu Arg His Ala Ilie Phe Gin Ile 80 Lys Leu Pro Thr Set Leu Asp Gin Leu His ftp Leu Pro Vat Set Asp 95 ALa Thr Ala Gin Leu Vat Set Gly Tht Set 110 115 Val Vat Phe Phe Vat Leu Glu Phe Leu Tyr Thr His Asp 1 40 Asn Asp Phe 155 Tyr Asn Met 170 Giu Vat GLy Pro ftp Phe Ala Arg Leu 220 Met Ala Asn 235 Phe Arg Leu 250 Gly Ala Ala Arg Thr Set 125 Ala Met His Gly Leu Gty Arg Vat 160 Leu His Arg Lys 175 Lys Asp Pro Asp 190 Ala Set Phe Met 205 Ala Trp ftp Tht Leu Leu Vat Phe 240 Phe Tyr Phe Gty 255 Set Gly Set Set 270 Gin Ala Set Asp 105 Leu Leu Asp lie Vat 120 GLy Leu Phe lie Thr 135 Arg Asn Atg Gin Leu 150 Tyt Ala ftp Phe Asp 165 His Asn His fhr Gly 165 Asn Pro GLy Ilie Vat 200 Set Met Ttp Gin Phe 215 Leu Leu Gly Ala Pro 230 Pro lie Leu Set Ala 245 Met Pro His Lys Pro Gtu Pro Pro Ala Vat Met Asn Trp Trp Lys Set 275 280 Leu Vat Set Phe Leu Thr Cys Tyr His 290 295 285 Phe Asp Leu His Trp Gtu His His Arg Trp Pro Phe Ala Pro Trp Ttp Giu Leu 315 305 310 Asn Cys Arg Arg Leu Set Gly Arg Gly Leu Vat Pro Ala 320 325
Claims (9)
1. A method of controlling carotenoid production in a chromoplast and/or chloroplast containing tissue of a plant, the method comprising modulating an activity of p-C-
4-oxygenase in said chromoplasts and/or chloroplasts of said tissue, said P-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO:4, thereby controlling carotenoid production in said chromoplast and/or chloroplast containing tissue of said plant. 2. A method according to claim 1, wherein modulating said activity of said P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue is upregulating said activity of P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue. 3. A method according to claim 2, wherein upregulating said activity of P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue is by expressing in said plant tissue a recombinant P-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO:4. 25 4. A method according to claim 3, wherein said recombinant P-C-4-oxygenase has a transit peptide for targeting into said chromoplasts and/or chloroplasts.
5. A method according to claim 4, wherein said transit peptide is of Pds.
6. A method according to any one of claims 3 to wherein said recombinant P-C-4-oxygenase is expressed in said chromoplasts and/or chloroplasts.
7. A method according to any one of claims 3 to 6, wherein said recombinant P-C-4-oxygenase is expressed in a H:\RBell\Keep\57796-01.doc 2/12/03 48 plant cell or cytoplasm.
8. A method according to claim 1, wherein modulating said activity of P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue is downregulating said activity of P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue.
9. A method according to claim 8, wherein downregulating said activity of P-C-4-oxygenase in said chromoplasts and/or chloroplasts of said tissue is by expressing in said plant tissue antisense molecules capable of hybridizing under physiological conditions with a P-C-4- oxygenase messenger RNA encoding a polypeptide having an amino acid sequence at least 80% identical to SEQ ID NO: 4. A plant overexpressing a recombinant P-C-4-oxygenase in chromoplasts and/or chloroplasts of chromoplasts and/or chloroplasts containing tissue of said plant, as compared to a wild type plant, said recombinant P-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO: 4. S 25 11. A plant underexpressing a recombinant P-C-4-oxygenase in chromoplasts and/or chloroplasts of chromoplasts and/or chloroplasts containing tissue of said plant, as compared to a wild type plant, said recombinant P-C-4-oxygenase having an amino acid sequence at least 80% identical to SEQ ID NO: 4.
12. A method according to claim 1, substantially as herein described with reference to the examples and 3 figures.
13. A plant according to claim 10 or claim 11, substantially as herein described with reference to the H!\RBell\Keep\57796-01.doc 2/12/03 49 examples and figures. Dated this 2 nd day of December 2003 YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM By their Patent Attorneys GRIFFITH HACK Fellows Institute of Patent and Trade Mark Attorneys of Australia i[ H:\RBell\Keep\57796-01.doc 2/12/03 I
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU57796/01A AU771135B2 (en) | 1996-10-28 | 2001-08-03 | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/742605 | 1996-10-28 | ||
| AU47436/97A AU732842B2 (en) | 1996-10-28 | 1997-10-03 | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
| AU57796/01A AU771135B2 (en) | 1996-10-28 | 2001-08-03 | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU47436/97A Division AU732842B2 (en) | 1996-10-28 | 1997-10-03 | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5779601A AU5779601A (en) | 2001-10-04 |
| AU771135B2 true AU771135B2 (en) | 2004-03-11 |
Family
ID=32034620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU57796/01A Ceased AU771135B2 (en) | 1996-10-28 | 2001-08-03 | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU771135B2 (en) |
-
2001
- 2001-08-03 AU AU57796/01A patent/AU771135B2/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| KAJIWARA ET AL., PLANT. MOL. BIOL. 1995, 29: 343-352 * |
| LOTAN ET AL.; FEBS LETTERS; 1995; 364: 125-128 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5779601A (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6218599B1 (en) | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants | |
| AU749302B2 (en) | Novel carotenoid-producing bacterial species and process for production of carotenoids using same | |
| Walter et al. | Carotenoids and their cleavage products: biosynthesis and functions | |
| Mann et al. | Metabolic engineering of astaxanthin production in tobacco flowers | |
| Harker et al. | Biosynthesis of ketocarotenoids in transgenic cyanobacteria expressing the algal gene for β-C-4-oxygenase, crtO | |
| Hirschberg et al. | Carotenoids in cyanobacteria | |
| Baranski et al. | Carotenoid biosynthesis and regulation in plants | |
| EP0746615A1 (en) | Dna constructs, cells and plants derived therefrom | |
| Zhu et al. | Nicotiana glauca engineered for the production of ketocarotenoids in flowers and leaves by expressing the cyanobacterial crtO ketolase gene | |
| EP1611243A2 (en) | 4-ketocarotenoids in flower petals | |
| US7695931B2 (en) | Carotenoid hydroxylase gene, method for preparing hydroxylated carotenoid, and novel geranylgeranyl pyrophosphate synthase | |
| WO2007124135A2 (en) | A new biochemical route to astaxanthin | |
| AU732842B2 (en) | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin | |
| AU771135B2 (en) | Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin | |
| US20050022269A1 (en) | Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof | |
| Sakuta et al. | Pigment biosynthesis II: Betacyanins and carotenoids | |
| Allen | Metabolic Engineering of the Astaxanthin Biosynthetic Pathway in Citrus | |
| AU2002318030A1 (en) | Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof | |
| Pierce | Genetic engineering of ketocarotenoid production in soybean | |
| Luo | Molecular and genetic studies related to zeta-carotene desaturation and carotenoid biosynthesis in maize and rice | |
| Nogueira | Optimisation of high-value isoprenoid production in plants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND INVENTION TITLE TO READ: NUCLEIC ACID SEQUENCE ENCODING BETA-C-4-OXYGENASE FROM HAEMATOCOCCUS PLUVIALIS FOR THE BIOSYNTHESIS OF ASTAXANTHIN |
|
| FGA | Letters patent sealed or granted (standard patent) |